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ABSTRACT
PERIVASCULAR WASTE METABOLITES CLEARANCE
IN CENTRAL NERVOUS SYSTEM (CNS)
by
Yiming Cheng
Efficient clearance of interstitial waste metabolites is essential for normal brain
homeostasis. Such effective clearance is hampered by the lack of a lymphatic system in
the brain, and the cerebrospinal fluid (CSF) is unable to clear large size waste metabolites
in the brain. Here, a novel idea that brain arterial endothelium and smooth muscle cells
reactivity regulates the clearance of these water-insoluble large size waste metabolites
through the perivascular dynamic exchange, and that low dose ethanol promotes this
perivascular clearance is proposed.
In Aim 1, the biodistribution of a large size waste metabolite (Amyloid-β protein
mimic) in rat perivascular space as a proof-of-concept is examined. Then the effects of
low dose alcohol (ethanol) for promoting perivascular clearance path are evaluated. The
result shows that ethanol increases perivascular clearance by enhancing the dilative
reactivity of arterial endothelial cells (ECs) and alpha-smooth muscle cells (α-SMCs) via
the activation of endothelial specific nitric oxide synthase (eNOS) and nitric oxide (NO)
production. In Aim 2, the underlying molecular mechanisms of low dose ethanol on the
perivascular clearance of waste metabolites is examined. The result shows that low dose
ethanol specifically activates eNOS in arterial wall and generates physiological favorable
level of NO without affecting the integrity of the Blood-Brain Barrier (BBB). This
vasodilator NO stimulates the dilative reactivity of ECs- α-SMCs, which promotes

the diffusive movement of waste metabolites from interstitial space/CSF to perivascularperivenous drainage path. Decrease in phosphorylation of myosin light chain in α-SMCs
and increase in arterial vessel diameter validates α-SMCs reactivity and movement of
waste metabolites towards perivascular space. In Aim 3, the contrast effects of chronic
moderate alcohol intake on perivascular clearance of waste metabolites is assessed. The
result reveals that chronic alcohol intake switches the induction of eNOS to inducible
nitric oxide synthase (iNOS), thereby generating high level of NO. This continuous
production of NO by iNOS in chronic alcohol exposure causes oxidative damage of the
arterial endothelial-smooth muscle layers, and reduces dilative reactivity. Decrease in
tight junction protein levels validates the BBB dysfunction, and increase in
phosphorylation of myosin light chain in α-SMCs validates the impairment of α-SMCs
reactivity, that are closely correlated with decrease in waste metabolites movement
towards perivascular clearance path.
The current work affords huge clinical relevance since aggregation of large size
waste metabolites like Ab protein around the perivascular space is a hallmark of
Alzheimer's disease. As such, the findings suggest new strategies for prevention and
treatment of neurological diseases that are associated with clearance of entangled
proteins.
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CHAPTER 1
INTRODUCTION

1.1 Objective
The objective of this dissertation is to present findings of large size waste metabolites
clearance from brain and the underlying regulation mechanisms. Clinically, large size
waste metabolites like tauopathy, prion-like proteinopathies, cerebral amyloid
angiopathy, and Aβ proteins are accumulated around the perivascular space (PVS) in
brain tissue from neurological diseases, including Alzheimer’s disease [1-3]. However,
how these entangled proteins that originate from brain interstitial space due to neuronal
activities translocate towards PVS and what are the underlying regulation mechanisms
are still unknown. Here, we hypothesize that a dynamic driving force that produces by
arterial vessel contraction/dilation creates a “pumping-like effect” within PVS, pooling
large metabolites towards PVS and promoting their clearance from inside brain to
systematic circulation. To validate this idea, we use low dose alcohol as a proof-ofconcept to stimulate dilative vascular reactivities. The rationale is that low dose alcohol,
through a signaling molecule Nitric Oxide (NO), is known to induce vessel dilation [4].
Epidermological evidence reveal that different alcohol drinking patterns exihibit
disctinctive corelations with onset and progression of neurological diseases that are
associated with entangled proteins aggregation [5]. A detail discussion regarding the
effects of alcohol will be expanded in Chapter 3-5.
As such, to address these questions, three specific aims are evaluated:
1) To determine the movement pattern of waste metabolites from cerebrospinal
fluid (CSF) and interstitial spaces to perivascular spaces (PVS);
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2) To examine that movement of waste metabolites at perivascular spaces is
associated with vessel dilation that regulated by interaction of brain endothelium and
smooth muscle cells;

3) To evaluate the contrast effect of low dose and chronic/moderate alcohol intake
on perivascular clearance.

1.2 Summary of Literatures
The brain is the command center of the body that regulates the vital functions of
circulation, respiration, motor function, metabolic activities, or autonomic outcomes.
The brain coordinates these non-stop activities at the expense of huge energy utilization.
This energy demand is achieved by active transport of nutrients across the endothelial
blood-brain barrier (BBB). Trafficking of xenobiotics and inflammatory agents into the
brain across the BBB or across the two other brain interfaces is harmful to brain cells,
resulting in waste metabolites production in the interstitial space (IS). Clearance of these
waste metabolites maintains the normal brain homeostatic functions, while aggregation
leads to serious neurological disorders. In the absence of lymphatic system, the CSF
flow serves as the clearance path in the CNS for water soluble peptides/solutes. The CSF
disposal path is unable to clear large size waste metabolites, such as Aβ protein in AD.
This section will first briefly discuss the existing entry routes of nutrients, immune cells
or xenobiotics into the brain. Focus will be on the clearance paths and mechanisms of
waste metabolites clearance in the CNS. This will include the mechanisms of waste
metabolites movement from IS to perivascular clearance (PVC), from IS-CSF-PVC, and
the exchanged from PVC to circulation. Therapeutic approach to improve the clearance
mechanisms for ameliorating neurological diseases will be concluded finally.
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1.2.1 Brain Barrier Interfaces
The brain is the command center of the body. It controls the many functions of
cardiovascular and systemic circulation, respiratory center, motor activities, metabolic
function, renal and gastrointestinal excretion, and autonomic nervous system.
Coordination of these numerous activities is carried out by the release of endocrinal
chemical messengers known as hormones. The brain does this by receiving signals from
sensory nerve cells, integrating and processing the information in interneurons, and
sending out the message to the effector tissue organs through the motor neurons.
Relaying of the message from the brain central nervous system to different part of the
body through peripheral nervous system is connected by brainstem via the spinal cord.
Constant supply of nutrients/minerals/ions across the selectively permeable blood-brain
interface known as the blood-brain barrier (BBB) meets the energy demand of the brain.
The localization of the tight junction proteins, protein/nutrient/ion transporters,
multidrug resistant efflux receptors, or enzymes at the BBB, selectively maintain the
ionic/nutrients homeostasis in the brain by dumping toxic agents in the circulation [6],
as illustrated in Figure 1.1. Thus, small size molecules like glucose, amino acid,
essential minerals/ions are transported across the BBB by carrier-mediated transporters,
whereas receptor mediated transporters translocated the large size peptides and proteins
[6, 7].
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Figure 1.1 Routes of transport across the BBB. Passive diffusion favors lipophilic
molecules; Carrier mediated transporters bi-directionally transport molecules influx
and/or efflux through BBB endothelial cell layer; receptor mediated transport requires
binding of ligand for transport of macromolecules such as glucose, peptides and proteins
across BBB endothelium (transcytosis); paracellular pathway through tight junctions
allows diffusion of for small molecules and cell trafficking.

In addition to endothelial BBB and blood-spinal cord barrier (BSCB) interfaces,
there are two other epithelial barriers that can render entry of molecules into the brain.
The interface between the blood and ventricular cerebrospinal fluid (CSF) is known as
the epithelial choroid plexus (CP), and the interface between the blood and CSF
subarachnoid is known as the epithelial arachnoid villi [8, 9]. The main function of CP
is the secretory source of cerebrospinal fluid for maintaining the fluid volume and ionic
balance in the CNS. The concept is essentially justified by the fact that CP serves as the
drainage sink in the brain. Recent findings reveal that this epithelial barrier is also
involved in immune cell trafficking [10] and pathogens entry interface [11, 12], as such
CP is apparently involved in the development of neurological diseases [13]. Most
recently, Uchida et al. (2019) showed the impairment of tight junction protein claudin-
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11 expression at the BBB, at the blood-spinal cord barrier (BSCB), and at the epithelial
arachnoid barrier in multiple sclerosis without affecting at the epithelial CP [14]. This
finding indicates that CP barrier is unlikely involved in the development of neurological
diseases. Choroid plexus is also implicated for supply of nutrients and signaling
molecules to brain parenchyma, as such, it may play a role in brain development and
aging [15]; however, this argument remains for open discussion. Another recent finding
implicates CP as a potential BBB bypass route for drug delivery in the CNS [16]. This
concept is based on the rationale that since carrier-mediated influx transporters or
receptors are expressed in CP epithelium, these molecules can be designed for drug
penetration across CP. The rationale uses the same principle that these molecules have
been employed for drug delivery across BBB. The function of the second epithelial
barrier known as the arachnoid villi interface between the blood and the CSF acts as the
main drainage channels of water-soluble peptides/solutes from CSF subarachnoid to
sagittal sinus for clearance. Intriguingly, micropinocytosis and vacuolization of
endothelial cells present in the stromal central core of the villi seem to facilitate a
bidirectional active transport across the arachnoid villi barrier [17].
Out of these two endothelial (BBB and BSCB) and two epithelial (CP and
arachnoid villi) barrier interfaces in the brain, the BBB is the primary
transport/trafficking route of nutrients, micro-organisms, immune cells, and xenobiotic
substances into the brain. The myeloid cells in the brain response to inflammatory event
in the form of phagocytosis, proteolytic degradation, and autophagy, which produces
harmful waste metabolites. Such harmful metabolites include components of
degenerating neurons and extracellular vesicles that are entrapped in the interstitial
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space (IS). Proper clearance of these waste metabolites from interstitial fluid/CSF
maintains the normal homeostasis function of the brain, while aggregation leads to
neurological disorders. Here, we focus the clearance mechanisms of these waste
metabolites from the brain with emphasis on perivascular clearance.
1.2.2 Interstitial Space Waste Metabolites
The main donor of fluid in the interstitial space is the blood circulation and cellular
secretion. The total volume of the interstitial fluid (ISF) is believed to be contributed by
passive diffusion of fluid from the circulation. The ISF contains cellular metabolites,
cellular shedded microvesicles and exosomes under normal condition, but ISF will
contain entangled proteins like amyloid-β in neuropathologic condition [18]. Therefore,
understanding the mechanisms of these waste metabolites movement from ISF to
terminal clearance path is exceedingly important for improving neurological diseases.
The drainage of water-soluble metabolites from ISF to CP, and to CSF compartments is
a major route for clearance of small-size and hydrophilic substances.
There are two school of thoughts on the mechanisms of ISF movement, the bulk
flow and diffusive movement [19]. Cserr, et al. (1977 and 1981) showed that a bulk flow
of the ISF independent of diffusion was responsible for clearance of waste metabolites
in the CNS [20, 21]. Their conclusion was based on the findings that deposition of
different molecular size tracers in rat brain interstitial space were drained at nearly
identical half-life rates with varying diffusion coefficients. It was estimated that the rate
of this bulk flow was 0.1–0.3 μL/g brain/min in rat brain [21, 22]. In recent time, the
hypothesis of ISF bulk flow mechanisms has been challenged by other critiques. Sykova
E and Nicholson C (2008) and Bakker EN et al. (2016) pointed out that the movement
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of ISF in the interstitial spaces was attributed to diffusive movement rather than bulk
flow mechanisms [23, 24]. Their argument was that first, the interstitial narrow spaces
between cells are too limited to allow significant ISF bulk flow. Second, the extracellular
matrix of the interstitial space contains repeated long chain polysaccharides like
glycosaminoglycans, which are negatively charged, hydrophilic, and can easily trap
water molecules and positive ions like sodium. These hindrance factors will not only
deter the bulk flow of interstitial fluid, but also limit the movement of large size waste
metabolites in the interstitial space. Thus, the question of whether the ISF move through
bulk flow or passive diffusion mechanisms remains to be debated for further
verification. Based on the emerging multiphoton imaging time-dependent interstitial
bio-distribution of small, medium, and large size molecular weight fluorescent tracers,
we will discuss my thought in glymphatic section below.
1.2.3 Clearance of Waste Metabolites in Cerebrospinal Fluid (CSF)
The cellular metabolites, extracellular vesicles, degraded peptides, and other
degenerated cellular components contain in the interstitial fluid are mostly collected in
the choroid plexuses (CP). The C3 compartment CP is localized in the cerebrum and C4
is localized in the cerebellum regions of the brain. The C3 and C4 are connected by an
aqueduct. The interstitial fluid drainage sink (CP) and ventricular cerebrospinal fluid
(CSF) is separated by the epithelial choroid plexus barrier, through which collected
interstitial fluid is excreted into the CSF [25]. The CSF flow passes through the
interventricular foramina of the third ventricle to the fourth ventricle via aqueduct. From
the fourth ventricle, the fluid then enters the subarachnoid space (SAS) through a median
and two lateral apertures [26, 27]. The CSF containing the water-soluble waste
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metabolites, but not cells ultimately move through the subarachnoid space and it can
also reach to perivascular space [28, 29]. The water-soluble metabolites in the CSF
subarachnoid space is absorbed into sagittal venous sinuses through arachnoid
granulations. The evident came from the work of Weed et al. (1914), who found that
non-toxic tracers injected into CSF crossed arachnoid granulations along sagittal sinus
and eventually penetrated into dura wall of the sinus [30, 31]. The absorption of CSF
dye arachnoid granulations was further confirmed by electron microscopy studies,
which showed that the presence of pressure-sensitive vacuolation cycle of pores indicate
the one-way valves transcellular flow [32]. The CSF contents in the sagittal sinus, most
likely at the confluence of sinus exits along the myelin sheath of olfactory bulbs through
cribriform plate [33], which is then believed to deliver into the deep cervical lymph
nodes through nasal lymphatics [34]. This drainage path from subarachnoid space to
nasal lymphatic system was further confirmed in seven different species using microfils
tracers [35]. Recently, these lymphatic vessels have been investigated in rodents by
using specific antibodies [36, 37].
In summary, Figure 1.2 schematic presentation illustrates the intracranial CSF
flow. It is important to emphasize here that the exchange of waste metabolites from
subarachnoid to superior sagittal venous sinus may account only the water-soluble small
size metabolites. This is because the granulation at the arachnoid microvilli barrier
restrict the clearance of large size waste metabolites. As such, the clearance mechanisms
of large size waste metabolites Aβ proteins from the interstitial space or from the CSF
remains to be investigated. To this end, emerging findings such as the glymphatic
hypothesis and our most recent published article on perivascular clearance mechanisms
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revealed the clearance mechanisms of large size waste metabolites from the interstitial
space or from the CSF circulation.

Figure 1.2 Schematic presentation of the intracranial CSF flow. CSF is produced by
choroid plexus and flows from the third ventricle to the fourth ventricle through cerebral
aqueduct. After circulating over hemispheres, CSF is absorbed into superior sagittal
sinus, transverse sinus, and sigmoid sinuses via arachnoid villi, as well as efflux from
the CNS along olfactory nerves through cribriform plate to nasal lymphatics and
eventually to cervical lymph nodes.

1.2.4 Glymphatic System
Glymphatic hypothesis proposed by Iliff JJ, Nedergaard M, et al. (2012) revealed the
continuously exchange of interstitial fluid (ISF) and cerebrospinal fluid (CSF) in the
brain compartments [29]. According to this hypothesis, the exchange is facilitated by
aquaporin-4 (AQP4) water channels that are expressed in highly-polarized astrocytic
end feet. In that, CSF from subarachnoid spaces fluxed into deep brain tissues along pial
and penetrating arterioles and into the brain parenchyma towards perivenous spaces,
which is facilitated by the convective function of astrocytic AQP4 [29, 38]. Figure 1.3
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illustrates the convective interstitial flow towards perivenous spaces surrounding deep
veins. They showed that water-soluble waste metabolites in ISF were collected and
carried towards perivenous space, from where metabolites were drained to lymph nodes
and systemic circulation.
The evidence was shown by imaging the bio-distribution of small size (Texas Red:
3 kD), medium size (Ovalbumin, 647 kD), and large size (FITC-d2000 kD) molecular
weight injection in mice through cisterna magna. It was observed that the tracers rapidly
entered the cortical pial arteries, then fluxed into perivascular spaces along the
penetrating arterioles, which was distinguished in Tie2-GFP:NG2-DsRed double
reporter mice. The small size tracer was found to exit primarily along the central deep
veins and lateral-ventral caudal rhinal veins, while the medium and large size tracers
accumulated at perivascular and peri-arterial spaces respectively in time-dependent
manner. Using AQP4 knockout mice, this same group of investigators validated the
proof-of-concept that astrocytic AQP4 was in part responsible for the clearance of
radiolabeled Aβ1-40 peptide because they observed 55% reduction of Aβ1-40 peptide
clearance in AQP4 knockout mice compared with wildtype [29, 38-40]. This idea of
glymphatic hypothesis is further embraced by the independent studies of other
investigators [41]. However, on the basis of time-dependent movement of tracers as
stated above, the movement of medium to large size metabolites in interstitial fluid
favors diffusion rather than the bulk flow mechanism of glymphatic hypothesis.
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Figure 1.3 Movement of solutes in ISF and CSF through the glymphatic pathway. CSF
from subarachnoid space fluxes into brain from perivascular spaces and exchanged with
ISF. The exchange was facilitated by aquaporin-4 (AQP4) water channels that highly
expressed in perivascular astrocyte end-foot. The bulk movement of CSF into brain
drives the convective flow of ISF and interstitial solutes to perivenous route.

The reproducibility of bulk flow mechanism is questioned by several most recent
publications. Some investigations argued that clearance of waste metabolites in
interstitial fluid is a passive diffusion and not a bulk flow convective transport [42, 43].
This argument is based on the size of metabolites. A model of diffusive and convective
transport in brain extracellular space was designed to illustrate the validation in support
of this argument. Findings from this model stated that diffusion alone [44] or combined
effects of diffusion and macroscopic fluid motion [45] is responsible for transport of
waste metabolites in brain parenchyma rather than bulk flow. The combined effects
appear to reconcile the conflicting transport mechanisms of solutes in ISF or in

11

perivascular space. This is in parallel with the findings that cyclic changes in arterial
pressure produces mixing of flow in opposite directions in different spaces of the arterial
wall [46]. It is likely that convection can assist the movement of solutes into and out of
the ISF without producing the net flow of fluid as required by glymphatic system. The
diffusive molecular flow along the peri-arterial sheaths into subarachnoid CSF [47], and
the diffusive drainage of waste metabolites from brain parenchyma into the basement
membrane of capillaries [28] also argued against the glymphatic hypothesis.
We discuss here that the transport of small size water-soluble waste metabolites
could be mediated by glymphatic function. The missing piece is the accumulation of
large size metabolites at the perivascular space, where glymphatic system does not
account for the clearance mechanisms. This concept is clinically important because
aggregation of entangled proteins at perivascular space is a hallmark of certain
neurological diseases like Alzheimer’s disease and cerebral amyloid angiopathy [1, 2,
48]. Unravelling the clearance mechanisms of these entangled proteins from
perivascular to blood circulation would be novel for ameliorating the relevant
neurological diseases. Our recent findings describe this novel clearance mechanisms at
the perivascular space, which is discussed in perivascular clearance section.
1.2.5 Meningeal Lymphatic Vessels
Lymphatic system is critical for maintenance of physiological homeostasis and immune
surveillance. It is a conventional believe that the central nervous system (CNS) lacks the
lymphatic vessels. Recently, Aspelund et al., 2015 and Louveau et al., 2015,
independently reported the existence of dura lymphatic vessels, known as the meningeal
lymphatic vessels in the meninges of the brain [36, 37]. They showed this evidence by
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positive stain of lymphatic endothelial cells marker hyaluronan receptor 1 (Lyve-1) and
vascular endothelial growth factor receptor 3 (VEGFR3) marker along the superior
sagittal and transverse sinuses.
Aspelund et al., 2015, concluded that dural lymphatic vessels absorb CSF from the
adjacent subarachnoid space and from brain ISF through glymphatic system, in which
CSF is then transported into deep cervical lymph nodes via foramina at the base of the
skull [36]. They validated this drainage route by nearly complete absence of tracer
accumulation in cervical lymph nodes in transgenic mice deficient of dural lymphatic
vessels compared with wild-type after injection of tracer into the CSF. Louveau et al.,
2015, found that the meningeal lymphatic cells were able to transport fluid and immune
cells from the CSF and clear them to the deep cervical lymph nodes [37]. Their discovery
of meningeal lymphatic function in the CNS becomes highly significant in the context
of immune cell surveillance since the development of many neurological diseases
involve inflammatory process. The findings of Aspelund et al. (2015) seems to connect
with glymphatic hypothesis, but the CSF drainage route in meningeal lymphatic system
appears to exit at the deep cervical lymph nodes, similar to conventional CSF exit. Here,
we illustrate the possible connection of CSF flow, glymphatic and meningeal lymphatic
system clearance route, Figure 1.4. Glymphatic system depicts the exchange of CSF/ISF
waste metabolites at the perivascular space towards perivenous space, while meningeal
lymphatic system accounts for cervical lymph nodes clearance route.
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Figure 1.4 Connection of CSF circulation, glymphatic system and dura lymphatic
vessels in terms of clearance. Glymphatic system (black arrow depicted flow direction)
resided inside brain was responsible for small size water-soluble waste metabolites
clearance (black dots). Lymphatic vessels (black circle) presented in dura was postulated
to involve in waste metabolites clearance by granting access for waste metabolites that
were drained by glymphatic system.

It is possible that waste metabolites from perivenous space may gain access to
meningeal lymphatics through subarachnoid or along the drainage veins that can merge
into dura sinus. It may be still too early to embrace the meningeal lymphatic vessel as
clearance route of CNS waste metabolites because there is no direct evidence to strongly
support this argument. In fact, multiple paths of CSF drainage in the CNS that are
functionally and anatomically close to lymphatic vessels were known [49-51]. However,
the exact connection between those routes and lymphatic vessels is largely unknown.
This is because the precise location of lymphatic vessels, whether within subarachnoid,
inside the dura or bathed between these two layers needs to be unraveled [52].
Since meningeal lymphatic vessels are not directly connected to CSF
compartments, the primary route of CSF waste metabolites absorption from
subarachnoid into sagittal sinus will be across the arachnoid villi. The arachnoid
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microvilli barrier is permeable to small size water-soluble metabolites, as such the
clearance mechanisms of large size waste metabolites remains to be investigated further.
Thus, promoting the mechanisms of perivascular clearance becomes clinically
significant since entangled proteins like A-β protein or neurofibrillary tauphosphorylated protein are commonly aggregated at the perivascular space.
1.2.6 Perivascular Space Clearance Mechanisms
Perivascular space (PVS) is referred to the space surrounding the penetrating arterioles
when diving down into deep brain tissues from pial arteries [53, 54]. The fine structure
of PVS consists of vascular endothelial and glial cells. The glial layer of the astrocyte
end-feet forms the outer wall, which becomes continuous with the vascular membrane
and basal lamina as it penetrates into the deep brain [55, 56]. The PVS channels are
known to involve in CSF/ISF waste metabolites movement, as indicated by distribution
of horseradish peroxidase following lateral ventricle or subarachnoid space injection in
cats and dogs [3]. Recently, a dynamic exchange of fluorescently labeled tracer between
CSF/ISF and perivascular was shown in NG2-DS transgenic mice by using two-photon
microscopy imaging [29]. In fact, in the 70’s the PVS was implicated as a conduit of
waste metabolites sink similar to the choroid plexuses because injection of horse radish
peroxidase (HRP) tracer into striatum of rat was found to aggregate around the PVS
[20].
The assumption of PVS serving as a conduit sink in the CNS is significantly in
line with the accumulation of waste metabolites around vasculatures that are clinically
observed in certain neurological diseases. The classic examples of such waste
metabolites deposition around the perivascular space are the neuropathological
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observations of phosphorylated tau protein in cerebral amyloid angiopathy (CAA) and
aggregation of amyloid beta protein in Alzheimer’s disease [1, 2, 5, 48]. These
observations clearly suggest that PVS may be directly involved for the possible
clearance of large size waste metabolites like phosphorylated tau protein and Aβ protein,
which are transported by CSF, meningeal lymphatics and glymphatic function.
Intriguingly, the ApoE family of molecules (ApoE2,E3) when mediated by low-density
receptor protein (LRP1) seem to actively involved in the clearance of Aβ protein through
BBB trans-vascular transcytosis [52, 57, 58]. In fact, experimental observations have
shown that the trans-vascular clearance from brain to blood circulation across the BBB
is believed to account for more than 80% of amyloid-beta clearance [59-61]. However,
such findings are based on clearance of small Aβ peptide in normal physiological
condition. In neuropathological condition, aggregation of phosphorylated tau protein
and Aβ protein at the perivascular space still remains to be the hallmark of neurological
diseases. The formation of this hallmark phenomenon needs further investigation to
understand whether the aggregation of entangled proteins at the perivascular space is
due to onsite formation or being translocated from the ISF. Since the aggregated proteins
in AD are mostly originated from neuronal cell components, it is likely to translocate
from the interstitial fluid rather than onsite formation. The rationale is that unlike the
astrocyte end-feet, the location of neurons is not directly in contact with perivascular
endothelial cells.
Thus, we posit here two fundamental questions for further investigation. What is
the driving force that regulate the movement of these waste metabolites towards the
perivascular space, and how to improve the clearance of these metabolites from
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perivascular space into the circulation in a timely manner? Understanding the improved
mechanisms of the intertwined processes will be significant to alleviate this neurological
disease. To this end, my recent findings gain clinical significant in understanding the
underlying cellular and molecular mechanisms of waste metabolites movement towards
perivascular space. We have shown that large size waste metabolite injected into the
CSF directly or into the cortical interstitial fluid diffused towards perivascularperivenous space instead of clearing through the conventional CSF subarachnoid and
sagittal sinus exchange [62]. We indicated that the hindrance for this exchange is due to
the presence of arachnoid villi barrier between the two compartments which allows the
absorption of mostly small size water-soluble metabolites/solutes. As a result, these
stagnated waste metabolites are forced to move towards perivascular space, and we
postulated that the driving force that regulate the movement appears to be the dilative
reactivity of arterial endothelial cells and smooth muscle cells interactions.

17

Figure 1.5 Schematic presentation of waste metabolites clearance at the perivascularperivenous space. Arrows (orange) indicate the CSF subarachnoid flow and
perivascular-perivenous clearance path (black) of large size waste metabolites (red dots)
in neurodegenerative brain. Waste metabolites like β-amyloid proteins are aggregated
more inside the interstitial space due to the lack of lymphatic system in the brain. Less
metabolites are drained into the CSF flow due to less vessel dilative reactivity. In the
presence of low dose alcohol (right), dilative arterial vessel reactivity promotes the
dynamic movement of large size waste metabolites from interstitial fluid and interstitialCSF subarachnoid to perivascular-perivenous route. Reactivity of endothelial and
smooth muscle cells in arteries is mediated by alcohol-elicited eNOS activation and NO
production. From perivascular and/or perivenous spaces, large size metabolites are
exchanged into circulation through two postulated mechanisms: (1) trans-vascular
clearance to circulation from perivascular space, and (2) diffusion into circulation from
perivenous space.

The rationale is that reactivity of vascular smooth muscle cells was indicated to
govern the cerebral arterial pulsation driven perivascular CSF flow locally [63]. This
dynamic pulsatile pattern of neighboring blood vessels may exert significant attraction
on fluid movement towards perivascular space. In this, the bioavailability of nitric oxide
(NO), a potent vasodilator becomes essential to regulate dilative reactivity of cerebral
arterial endothelial cells and smooth muscle cells interactions. Thus, we examined the
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proof-of-concept that activation of brain endothelial specific nitric oxide synthase
(eNOS) by low dose ethanol could produce favorable physiological levels of NO for
increasing the cellular reactivity and increase diffusive movement of waste metabolites
towards perivascular space. The rationale was that moderate level of ethanol has been
shown to augment endothelial-SMCs dilative activity in placenta and pulmonary arterial
vessels [4, 64, 65]. In deed my recent findings revealed that a very low dose ethanol (5.0
mM, equivalent of 0.02% blood alcohol level) significantly enhanced the diffusive
movement of waste metabolites from ISF/CSF to perivascular-perivenous space [62].
We found that dilative reactivity of brain endothelial and smooth muscle cell was the
underlying cellular and molecular mechanisms for this improved diffusive clearance of
waste metabolites at the perivascular-perivenous space. Figure 1.5 illustrates the
underlying mechanisms of waste metabolites clearance at the perivascular-perivenous
space.
My findings also validated the exchange between perivascular-perivenous and
blood circulation by detecting fluorescent labeled large size waste metabolite in
systemic blood plasma after CSF/parenchyma injection. The question of whether the
maximum diffusion into the blood circulation takes place at the perivascular space or at
the perivenous space, and/or both remains future studies. Other studies indicated that
perivenous flow may gain access to meningeal lymphatic vessels or large caliber
draining veins, which may then merge to form the dura sinus [29, 39], but it has no direct
evidence. This rationale is unlikely because lymphatic vessels appear to localize in dura
leaflets or inside surface of the dura that are separated from the CSF, as such it will not
have access to waste metabolites. On the basis of tissue organ environmental
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considerations, Rapper et al. (2016) concluded that unlike the function of the peripheral
lymphatic system, the meningeal lymphatics may not involve in CSF waste metabolites
drainage system [52]. In summary, the movement of Aβ protein from ISF/CSF
subarachnoid to perivascular space is regulated by dilative reactivity of brain arterial
smooth muscle and endothelial cells interactions. This clearance path can be
significantly promoted by low dose ethanol via eNOS-induced NO production.
1.2.7 Conclusion
Efficient clearance of interstitial waste metabolites in CNS is essential for normal
maintenance of brain homeostasis. We describe here the up-to-date emerging
discoveries of various possible clearance systems operating in the brain apart from the
conventional cerebrospinal fluid (CSF) clearance path. This includes glymphatic
system, meningeal lymphatic vessels, diffusive movement of waste metabolites from
ISF/CSF to perivascular space, and perivascular clearance of waste metabolites across
the BBB trans-vascular vessels. Each of this individual discovery does carry significant
impact on current scientific knowledge gap towards the understanding of waste
metabolites clearance and immune cells surveillance function in the CNS. Apart from
the focal finding of astrocytic aquaporin-4 mediated clearance path, the glymphatic
system does reveal the movement of waste metabolites like amyloid-beta towards the
perivascular space. Whether the movement of these waste metabolites from ISF/CSF to
perivascular space is regulated by diffusion or a bulk flow mechanisms needs further
verification. However, aggregation of waste metabolites at the perivascular space
prompted the clearance path through the BBB trans-vascular or re-entry into the
capillary basement membranes [66], which is relevant for eventual prevention of
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neurological disease like Alzheimer’s disease. Thus, improving the newly discovered
CNS clearance path(s) in the absence of traditional lymphatic drainage system assumes
great therapeutic relevance for many neurological diseases.
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CHAPTER 2
MATERIALS AND METHODS

2.1 Materials and Reagents
Reagents: Primary antibodies rabbit anti-GFAP, iNOS, vWF, Glut-1, ZO-1, Occludin,
Claudin-5, phospho-MLC; mouse anti-SMA, eNOS, 3-NT and anti-beta actin were
purchased from Abcam (Cambridge, MA); anti-endomucin was purchased from
Invitrogen (Carlsbad, CA). Rabbit anti- phosphor-MYL9, phospho-MYPT1/MYPT2
and phosphor-MYLK were purchased from Invitrogen (Carlsbad, CA). All secondary
Alexa Fluor conjugated antibodies were purchased from Invitrogen (Carlsbad, CA).
Table 2.1 summarizes the details of the antibodies source, catalog numbers, and
dilutions factors that were used for immunofluorescence staining and western blotting
analyses.
A highly stable fixable dextran-conjugated Fluorescein, 2,000,000 MW (FITCd2000) was purchased from Thermo Fisher Scientific (Waltham, MA), Nω-Nitro-larginine methyl ester (L-NAME, a NOS inhibitor) was purchased from Sigma-Aldrich
(St. Louis, MO).
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Table 2.1 Antibodies Source, Catalogue Numbers, and Dilutions Factors for
Immunoflurescence Staining and Western Blotting Analyses

Antibody

Marker

Anti--SMA

Alpha
smooth
muscle actin

Anti-GFAP

Astrocyte

Anti--actin

Beta-actin

Anti-Endomucin

Endomucin

Anti-iNOS
Anti- 3Nitrotyrosine
Anti-Von
Willebrand
Factor
Anti-Glucose
Transporter 1
Anti-ZO1
Anti-Occludin
Anti-Claudin 5
Anti- Myosin
light chain
(phospho S20)
Anti-phosphoMYL9 (Thr18,
Ser19)
Anti-PhosphoMYPT1/MYPT2
(Ser668, Ser618)
Anti-PhosphoMYLK
(Ser1760)

Inducible
nitric oxide
synthase
3Nitrotyrosine
Von
Willebrand
Facto
Glucose
Transporter 1
ZO-1 tight
junction
protein
Occludin
Claudin-5
Myosin light
chain
(phospho
S20)
pThr18/Ser19
of myosin
light chain 2
MYPT1/2
(PhosphoSer668/Ser61
8)
myosin light
chain kinase
(MLCK) that
contains
serine 1760

Vendor

Abcam

Catalogue #
ab7817

Dilution
for IHC

Dilution
for WB

1:250

1:1000

Abcam

ab7260

1:250

--

Abcam
Invitro
gen

ab8226
14-585182

--

1:2000

1:200

--

Abcam

ab15323

1:250

1:1000

Abcam

ab110282

1:250

1:1000

Abcam

ab154193

1:250

1:1000

Abcam

ab652

1:250

1:1000

Abcam

ab96587

1:250

1:1000

Abcam
Abcam

ab224526
ab15106

1:250
1:250

1:1000
1:1000

Abcam

ab2480

1:250

1:1000

Invitro
gen

PA517727

1:200

1:1000

Invitro
gen

PA564805

1:200

1:1000

Invitog
en

44-1085G

--

1:1000

2.2 Methods
2.2.1 Animals and Cell Culture
Eight-week old male Sprague-Dawley rats were purchased from Charles River
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Laboratory (Wilmington, MA). Animals were maintained in sterile cages under
pathogen-free conditions in accordance with institutional ethical guidelines for care of
laboratory animals, National Institutes of Health guidelines, and the Institutional Animal
Care Use Committee, Rutgers University.
For low dose/acute study: animals were randomly divided into 4 experimental
groups (6 rats/group), 1) Control, 2) 5.0 mM ethanol, 3) 5.0 mM ethanol + L-NAME,
and 4) L-NAME. A working concentration of 5.0 mM ethanol (EtOH, 0.230 g/kg body
weight) was determined from a dose-dependent study of 0.046–0.460 g/kg body weight
reconstituted in saline.
For chronic alcohol animal model: a pair-fed procedure was employed as
previously described [67]. In brief, rats were initially acclimated to Lieber DeCarli
control and 29 % calorie (5% vol/vol) ethanol (EtOH) liquid-diets from Dyets Inc for 1
week prior to weight-match pair feeding regimens for 10 – 12 weeks. Pair feeding of
control animals (15 rats, 7 rats for acute/dose) was based on the amount of ethanol-liquid
diets consumed by ethanol animals (8 rats). The macronutrient composition of controlliquid diets as percent of total calories is 47% carbohydrate, 35% fat, and 18% protein;
and that of ethanol-liquid diets is 35% fat, 18% protein, 19% carbohydrate and 29%
ethanol caloric intake. Daily food intake and weekly body weights were recorded.
2.2.2 Drug Concentration
Ethanol or the NOS inhibitor L-NAME (10 mg/kg body weight) constituted in saline
was injected through tail vein using a 27 G needle. Detailed experimental conditions for
control tracer dye bio-distribution through cisterna magna or intracortical route of
injection is described below. For group 2, ethanol was administered 15 min prior to
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tracer dye injection following anesthesia, while L-NAME was administered 5 min prior
to ethanol and 20 min prior to tracer dye injection for group 3. For group 4, L-NAME
was given 20 min prior to tracer dye injection.
2.2.3 Injection of Fluorescence Marker
All rats were anesthetized by intraperitoneal injection of 0.1 ml of ketamine (80–100
mg/kg) + xylazine (5–10 mg/kg) mixture using a 26-gauge needle as approved by the
Panel on Euthanasia of the American Veterinary Medical Association (AVMA).
Anesthetized rats were fixed in a stereotaxic frame. Then a total volume of 10 μl
fluorescence tracers diluted in artificial CSF at a concentration of 5 mg/ml (0.5%) was
injected via the cisterna magna at a rate of 2 μl/min over 5 min using 30-gauge needle
syringe pump (Harvard Apparatus). The body temperature of animals was maintained
at 37 °C with a temperature-controlled warming pad. Heart rate and respiratory rate were
monitored through MouseSTAT® Pulse Oximeter & Heart Rate Monitor Module. To
visualize the time-dependent movement of tracer from subarachnoid space into the brain
parenchyma following cisterna magna injection, animals were perfusion fixed at 30 min,
1 h and 2 h before surgically removing the intact brain tissues. A thickness of 40 μm
tissue slices were cut and mounted on a glass covered slides and tracer bio-distribution
was imaged ex-vivo by epifluorescence microscopy.
2.2.4 Intracortical Tracer Injection
All rats were anesthetized as describes above. A total volume of 1.0 μl fluorescent
labeled tracers were injected stereotactically into the brain parenchyma at a rate of
10 nl/s that controlled by a micro syringe pump (UMP3) from world precision
instruments (Sarasota, FL). A 33-gauge needle was inserted via a small burr hole into
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the brain at the following coordinates: right parietal skull, 2.0 mm lateral from the
sagittal suture and 3.0 mm caudal from the coronal suture. After needle insertion, 30 min
was given to allow the needle track to swell closed. To evaluate tracer bio-distribution,
animals were perfusion-fixed between 1 – 4 h after injection and tissue slices (40 μm)
were subsequently imaged as describe above.
2.2.5 Ex-vivo Fluorescence Imaging
Multi-channel whole-slice montages were acquired with Leica Aperio Versa 200 digital
pathology grade slide scanner. This included separate DAPI, Green and Red emission
channels. Exposure levels were determined based upon un-injected control slices, then
maintained constant throughout the study. Fluorescent intensities were quantified using
AreaQuant software specifically designed for this imaging application (Leica
Biosystems) and expressed as average fluorescence intensity/unit area. This imaging
technique allows for visualization of micro-structural details and digital scanning affords
the ability to image large brain regions with no loss of resolution. In order to quantify
fluorescence intensities, regions of interest were manually outlined in different brain
section. For each channel (green 488 nm and red 594 nm), a minimum intensity
threshold value was selected to exclude any background fluorescence from our
calculation. The AreaQuant algorithm then determines if the intensity value of each
pixel enclosed in the outlined region exceeds the minimum intensity threshold and
outputs the total area of positive stain for each brain regions, the average intensity in
each channel, and the expression profile of the tracers.
2.2.6 Surgery for Two-photon in-vivo Imaging
Rat surgery for two-photon imaging was as described by Eyo et al. [68]. Briefly, rats
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were anesthetized and craniotomy (4.0 × 4.0 mm) was performed over the right parietal
skull, 2.0 mm lateral from the sagittal suture and 3.0 mm caudal from the coronal suture,
with the dura intact. A head plate was glued to the skull around the cranial window, and
the plate was screwed into a customized stage and placed under the two-photon
microscope. To visualize vasculatures, 1 ml BBB impermeable Texas Red-dextran 70
(MW 70 kDa; 1% in saline, Invitrogen) was injected through tail vein 30 min before
imaging. Rats were maintained under anesthesia and body temperature was kept at 37 °C
with a warming pad for the duration of imaging. Heart rate and respiratory rate were
monitored as previous described.
2.2.7 In-vivo Imaging
Two-photon microscopy setting and operation were as described [69]. In brief, twophoton fluorescence microscopy (2PFM) was performed using a Bruker Ultima
fluorescence microscope equipped with a Coherent Mira 900 laser source (200 fs,
76 MHz). The excitation wavelength was 860 nm for dextran-conjugated FITC and
Texas Red, and the emission was collected using two external nondescanned PMT
detectors (NDD) at 525–600 nm. A 20 × , 1.0 N A. water immersion objective was
employed for the 2PFM. A laser line-scan or ROI-based local excitation was used to
better evaluate vessel diameter change and tracer movement over time.
2.2.8 Line Scan
To measure vessel diameters, 9000 ms X–Y line scan was conducted orthogonal to the
vessel axis in penetrating arterioles 50–100 μm below the cortical surface. A customized
Matlab code was developed to extract and calculate vessel diameter over time.
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2.2.9 Immunofluorescent Staining
For tissues: Immunostaining was described in previously publications [67, 70]. In brief,
frozen brain tissue sections (10 μm thickness) on glass slides were washed with PBS,
fixed in acetone-methanol (1∶1 v/v) fixative, blocked the cellular antigen with 3% bovine
serum albumin at room temperature for 1 h in the presence of 0.4% Triton X-100 and
incubated with respective primary antibodies such as rabbit anti-alpha smooth muscle
actin(SMA) (1∶250 dilution), rabbit anti-GFAP (1∶250 dilution) and mouse anti-eNOS
(1:250 dilution) for overnight at 4 °C. After washing with PBS, tissue sections were
incubated for 1 h with secondary antibody: anti-rabbit-IgG Alexa fluor 594 (1:400
dilution) for GFAP and mouse-IgG Alexa fluor 594 (1:400 dilution) for SMA and eNOS.
Cover slips were then mounted onto glass slides with mounting solutions containing
DAPI (Invitrogen), and fluorescence microphotographs were captured by Leica Aperio
Versa 200 digital pathology grade slide scanner.
For cells: Immunostaining procedure was described in previously publications
[67, 70]. In brief, cells cultured on glass slides were washed with PBS, fixed in
paraformaldehyde (4%) fixative, blocked the cellular antigen with 3% bovine serum
albumin at room temperature for 1 hr in the presence of 0.4% Triton X-100 and
incubated with respective primary antibodies for overnight at 4°C. After washing with
PBS, cells were incubated for 1 hour with secondary antibody. Cover slips were then
mounted onto glass slides with mounting solutions containing DAPI (Invitrogen), and
fluorescence microphotographs were captured by Leica Aperio Versa 200 digital
pathology grade slide scanner.
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2.2.10 Western Blot
A cerebral blood vessel isolation was performed using mesh filtration to concentrate
protein content that originated solely from vasculatures [71]. In brief, fresh brain tissue
was homogenized on ice using pestle in HBSS solution with 1% HEPES. Whole brain
homogenization was centrifuged at 2,000×g for 10 min and 4,400×g for 15 min (in 20%
dextran) at 4 °C. Then, pellet containing vessels was re-suspended into ice-cold 1%
bovine serum albumin (BSA) solution and proceed to mesh filter (20 um) for isolation.
Western blot was performed as described by previous publication [72]. In brief, isolated
brain vessels or cell lysis from respective experimental conditions were lysed with
CellLytic-M (Sigma) for 30 min at 4 °C, and centrifuged at 14000×g. The concentrations
of protein from tissue homogenates were estimated by bicinchoninic acid (BCA) method
(Thermo Fisher Scientific, Rockford, IL). Protein load was 20 μg/lane in 4–15% SDSPAGE gradient gels (Thermo Fisher Scientific). Molecular size separated proteins were
then transferred onto nitrocellulose membranes, blocked with superblock (Thermo
Fisher Scientific), and incubated overnight with respective primary antibody to alphaSMA, eNOS and beta-actin (all diluted at 1:1000) at 4 °C, followed by washes and
incubation

with

horse-radish

peroxidase

conjugated

secondary

antibodies

(corresponding to primary, diluted at 1:12000) for 1 hr at room temperature.
Immunoreactive bands were detected by West Pico chemiluminescence substrate
(Thermo Fisher Scientific). Data was quantified as arbitrary densitometry intensity units
using the ImageJ software package.
2.2.11 Real-time NO Detection
For tissues: Briefly, freshly isolated brain tissues was prepared in ice-cold oxygenated
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(95% O2 and 5% CO2) artificial cerebrospinal fluid (aCSF). Coronal slice (1 mm) was
prepared using brain matrices and transferred to a recovery chamber for 30 min with
oxygenated aCSF at 37 °C temperature before experiment. NO was measured using free
radical analyzer with a specific NO probe (TBR4100, World Precision Instruments,
Sarasota, FL). The NO probe is able to polarographically measure the concentration of
NO gas in solutions. The system was calibrated using different concentrations of NO
donor S-Nitroso-N-acetyl-dl-penicillamine (SNAP, Cayman Chemical) to generate a
standard curve. To block endogenous NO, oxygenated aCSF containing 1 mM L-NAME
was added to tissue 30 min prior experiments. Probe was positioned ~1 mm above tissue
surface using a micromanipulator (World Precision Instruments, Sarasota, FL) and
baseline of NO release was recorded prior EtOH treatment. Tissue was then treated with
5 mM EtOH (in aCSF) and subsequently with 1 mM L-NAME (in aCSF). NO
concentration was recorded using NO probe as described at the same time. Experiment
was simultaneously performed with control from the same tissue source to exclude
experimental drift in NO release unrelated to the study.
For cells: To block endogenous NO prior experiment, cells were firstly incubated
with medium containing 50 µM L-NAME for 30 min. During experiment, probe was
positioned ~ 1 mm above cell layer surface using a micromanipulator (World Precision
Instruments, Sarasota, FL) and baseline of NO release was recorded prior EtOH
treatment. Cells were then treated with 10 mM EtOH or 15 µM SNAP (in medium) and
data was collected at 10, 20, 30, 60 and 120 min respectively. Experiment was
simultaneously performed with control from the same cell source to exclude
experimental drift in NO release unrelated to the study.
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2.2.12 Plasma Fluorescence Intensity
Whole blood was collected from the tail vein before sacrificing and stored in citratetreated blood tubes (Fisher) to avoid coagulate. To extract plasma, whole blood was
centrifuged at 1000×g for 10 min (4 °C). Clear supernatant was carefully collected and
aliquoted into small tubes. Arbitrary fluorescence intensity was determined in 96-well
plate using plate reader (Molecular Devices) at 490 excitation and 525 emission
wavelengths.
2.2.13 Endothelial and Smooth Muscle Cells Culture
Rat primary brain vascular endothelial cells and were purchased from ScienCell
(Carlsbad, CA) and rat primary brain vascular smooth muscle cells were purchased from
Cell Biologics (Chicago, IL). Briefly, cells were cultured on collagen-coated flash in
complete medium with supplements provided by vendor.
2.2.14 Cell Toxicity Assay
Endothelial cells and smooth muscle cells (1×104/well, determined by cell number
titration) were seeded into a 96-well plate respectively and incubated in at 37°C under a
humidified atmosphere of 5% CO2 and 95% air for 24 hours prior experiment to allow
fully attachment. Cells were then incubated with medium containing different
concentration of alcohol (0, 2.5 mM, 5 mM, 10 mM and 20 mM) for 2 hours. Toxicity
was subsequently measured by using MTT assay kit (Abcam). In brief, adding 50 μl of
MTT reagent to each well, and then incubated the plate at 37°C for 3 h. After incubation,
150 μl of MTT solvent was added to each well and absorbance was measured at 590 nm
using a multi-well spectrophotometer (Molecular Device).
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2.2.15 Data Analysis
All results values are expressed as the mean ± SE, N = 6. Statistical analysis of the data
was performed using SPSS 24 (IBM). In the present studies, wherever the numeric
values of N are indicated, it represents the actual number of animals/samples used for
that specific experiments or the actual number of experiments performed in cell culture
setting, and not the number of replicates per experimental condition. Comparisons
between samples were performed by ANOVA with Tukey’s post-hoc tests. Differences
were considered significant at *p < 0.05.
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CHAPTER 3
ALCOHOL PROMOTES WASTE CLEARANCE IN THE CNS VIA BRAIN
VASCULAR REACTIVITY

3.1 Summary
The efficient clearance of the interstitial waste metabolites is essential for the normal
maintenance of brain homeostasis. The brain lacks the lymphatic clearance system.
Thus, the drainage of waste metabolites in the brain is dependent on a slow flow of
cerebrospinal fluid (CSF) system. Glymphatic system claims the direct bulk flow
transport of small size water-soluble waste metabolites into to the perivenous space by
aquaporin-4 water channels of the astrocyte end-feet, but it did not address the diffusive
clearance of large size waste metabolites. In this chapter, we addressed the clearance
mechanisms of large size waste metabolites from interstitial fluid to perivascular space
as well as from CSF subarachnoid into perivascular space via the paravascular drainage.
A low dose ethanol acting as a potent vasodilator promotes the dynamic clearance of
waste metabolites through this perivascular-perivenous drainage path. We observed that
ethanol-induced increased in vascular endothelial and smooth muscle cell reactivity
regulated the enhanced clearance of metabolites. Here, we found that activation of
endothelial specific nitric oxide synthase (eNOS) by ethanol and generation of
vasodilator nitric oxide mediates the interactive reactivity of endothelial-smooth muscle
cells and subsequent diffusion of the CNS waste metabolites towards perivascular space.
By detection of tracer dye (waste metabolite) in the perivenous space and in the blood
samples, I further confirmed the improved clearance of waste metabolites through this
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unraveled interstitial-perivascular-perivenous clearance path. As such, we conclud that
alcohol intake at low-dose levels may promote clearance of neurological disease
associated entangled proteins.

3.2 Background
Efficient clearance of interstitial fluid (ISF) waste metabolites by cerebrospinal fluid
(CSF) flow is essential for normal healthy maintenance of brain homeostasis, because
unlike most tissue organs the brain lacks a lymphatic system. The classical view of the
CNS clearance system is that the interstitial fluid (ISF) contains the extracellular and
intracellular waste metabolites that are drained into choroid plexus [31], from here CSF
flows into subarachnoid space (SA) through the median and lateral apertures. CSF is
then exchanged into dural sagittal sinuses via a restricted granulation known as
subarachnoid microvilli, then the sagittal sinuses, merged at the confluence of sinuses,
are drained into nasal or cervical lymphatic vessels [26, 27, 30]. Johnston et al. (2010)
showed this path by filling the subarachnoid compartment of seven different species,
from small rodents to humans, with yellow microfil CSF tracer dyes to trace the drainage
path of CSF into nasal lymphatics [35]. They found that microfil was observed primarily
in the subarachnoid space around the olfactory bulbs and cribriform plate. The contrast
agent followed the olfactory nerves and entered extensive lymphatic networks in the
submucosa associated with the olfactory and respiratory epithelium.
Recently, Louveau et al. (2015) and Aspelund et al. (2015) have shown the
existence of dura associated lymphatic vascular system in the brain's meninges wholemount fixing the meninges still attached to the skull [36, 37]. They observed distinctive
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expression of lymphatic endothelial cells including lymphatic vessel endothelial
hyaluronan receptor 1 (Lyve-1) and vascular endothelial growth factor receptor 3
(VEGFR3) along the blood vessels of superior sagittal and transverse sinuses. The
involvement of dural lymphatic vessels for the drainage of metabolites in dural venous
sinus was shown by injecting tracers into the CSF of animals and by detecting the tracers
in the lumen of Lyve-1-expressing vessels and in the deep cervical lymph nodes [37]. It
was further confirmed that there was a significant reduction of tracers in Lyve-1expressing vessels and a complete absence of tracers in the cervical lymph nodes of
transgenic mice deprived of lymphatic vessels [36]. Since anatomical sites of lymphatic
vessels were strictly localized in brain dura meninges [36, 37, 52], as such transport of
soluble waste metabolites into lymphatic vessels would be dependent on CSF
subarachnoid circulation. Notably, the exchange of waste metabolites from
subarachnoid to superior sagittal venous sinus is valid only for water-soluble small size
metabolites because of granulated subarachnoid microvilli barriers. Thus, dural
lymphatic vessels, also known as meningeal lymphatic clearance system may not clear
large size waste metabolites.
The recently discovered glymphatic system showed a molecular size dependent
clearance profile of fluorescent dye tracers in the CNS, when tracers were injected
through intracisterna magna [29]. The small size tracer (Texas Red, 3 kDa) directly
entered the interstitial space and influx into the perivascular space along penetrating
arterioles. The clearance of this small size tracer from perivascular space into central
deep veins and lateral-ventral caudal rhinal veins is facilitated by aquaporin-4 (AQP4)
water channel of a highly-polarized astrocytic end feet. Such an AQP4 facilitated
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exchange between CSF and ISF is restricted to small size waste metabolites because the
medium size tracer (Ovalbumin, 647 kDa) gets accumulated at perivascular space within
3 hours of injection. The tracer then slowly penetrated into the basement membranes of
parenchymal capillaries and perivascular space of large caliber draining veins,
suggesting a capillary-venous drainage route. In contrast, a large size tracer (FITC, 2000
kDa) was found to be aggregated at the perivascular space, lacking a distinct clearance
path [29]. Injection of radiolabeled amyloid β1–40 (Aβ, a small peptide) into mouse
striatum was rapidly cleared through the glymphatic pathway since the clearance was
significantly diminished in AQP4 deficiency transgenic mice [29]. This further
implicates the importance of glymphatic system clearance in neurological disease, like
Alzheimer’s disease [29, 38-40], even though glymphatic system did not account for the
clearance of such large size waste metabolites in the CNS.
However, the reproducibility of the accredited bulk flow transport mechanism of
glymphatic hypothesis has been questioned by a number of most recent verification
studies. These investigations concluded that clearance of waste metabolites from the
brain is more of a diffusion rather than bulk flow convective transport, based on the
metabolites molecular size [42, 43]. In support of this argument, a model of diffusive
and convective transport in brain extracellular space stated that diffusion alone size [44]
or combined effects of diffusion and macroscopic fluid motion [45] is adequate to
account for transport of waste metabolites in brain parenchyma rather than bulk flow
alone. The later appears to be a more reconcile argument for such conflicting
experimental observations, notably the transport of solutes in opposite directions in the
perivascular space. This is in parallel with the findings that cyclic changes in arterial
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pressure produces mixing or flow in opposite directions in different spaces of the arterial
wall [46]. In this case, convection can assist the movement into and out of the cortex
without necessarily producing the net flow of fluid into the cortex as required by
glymphatic system. Furthermore, the diffusive molecular flow along the peri-arterial
sheaths into subarachnoid CSF [47], and the diffusive drainage of waste metabolites
from brain parenchyma into the basement membrane of capillaries [28] argued against
the glymphatic hypothesis.
The fact is that large size waste metabolites like tauopathy, prion-like
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated
around the perivascular space in brain tissue from neurological diseases [1, 2, 48]. Such
observations suggest that large size waste metabolites are not cleared by CSF,
glymphatic, or meningeal lymphatic systems. Here, we address the fundamental
questions of what dynamic force specifically drives the movement of these waste
metabolites towards perivascular space, and can we strategize to enhance the clearance
of these waste metabolites from perivascular space into the circulation? It has been
shown that the blood-brain barrier (BBB) trans-vascular clearance from brain to blood
provides functionally a major pathway for elimination of different waste metabolic
products from brain into the circulation including amyloid-beta, which is believed to
account for > 80% of amyloid-beta clearance under physiological conditions [59-61].
Thus, uncovering the mechanisms of moving the waste metabolites towards perivascular
space and the clearance of waste metabolites from perivascular space into the circulation
should have significant clinical impact for possible prevention of many neurological
diseases. We hypothesize that increasing the reactivity of brain arterial endothelial and
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smooth muscle cell function by low dose ethanol can enhance the dynamic diffusion of
water-insoluble large size CSF/interstitial metabolites into perivascular space and
subsequent clearance into the circulation. Here we test the idea that activation of brain
endothelial specific nitric oxide synthase (eNOS) by low dose ethanol produces potent
vasodilator nitric oxide that can diffuse readily into the underlying SMCs to cause
arterial vessel dilation through intracellular calcium signaling. The rationale is that
activation of eNOS by low concentration of ethanol elevates physiological NO levels
and augments endothelial-SMCs interactive reactivity [4, 64, 65]. This eNOS derived
NO acts as a potent protective brain vascular tone and vasodilation [70].

3.3 Results
In this study, we examined the idea that reactivity of endothelial and smooth muscle
cells plays a critical role in the interstitial-perivascular-perivenous clearance of large
size waste metabolites in the brain. Here we first focused on the dynamic bio-distribution
of a 2000 kDa fluorescent dye representing large size waste metabolites following two
different routes of injection, through cisterna magna and direct intracranial cortical
injection. Cisterna magna route directly deposits the tracer into the C3 region of CSFsubarachnoid flow, while deposition of tracer dye into the intracranial cortical region
move through the interstitial space. Stimulation of brain arterial endothelial and smooth
muscle cells reactivity by low dose ethanol was correlated to increase clearance of waste
metabolite through interstitial-perivascular-perivenous space. We observed that reactive
vascular endothelial-smooth muscle cell dilation and contraction regulates the diffusion
and clearance of waste metabolites via the interstitial-perivascular-perivenous path. The
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clearance path is supported by the present findings.
3.3.1 Injection of FITC-d2000 into C3 Region of CSF Flow Accumulates in
Perivascular Space via the Subarachnoid-paravascular Movement
To evaluate the movement pattern of large size waste metabolites in the brain, we first
injected FITC-d2000 (MW: 2000 kDa) directly into the CSF flow via cisterna magna
which bypass the interstitial movement. This large size fluorescence tracer represents
large size waste metabolite like A-β proteins, which is validated in Appendix E (Figures
E1 and E2). We then evaluated the bio-distribution of tracer in the brain at different
time points. We observed that a direct deposition of tracer into the C3 region of CSFsubarachnoid flow and penetrated into the perivascular space via the paravascular route
time-dependently. For example, in less than 30 min after intracistertna magna injection,
the subarachnoid (SAS) was filled with fluorescence tracer, but very little tracer
penetrated in less than 0.5 mm depth of paravascular area from SAS (Figure 3.1A). But
after 60 min, more tracer was observed penetrating deep into brain perivascular space
(Figure 3.1B – C). The magnified imaging data from Figure 3.1D – F showed the
biodistribution of aggregated tracer along the different segmental branches of arterial
vessel. These data suggest that waste metabolites from CSF flow can move into
perivascular space through subarachnoid-paravascular drainage path.
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Figure 3.1 Tracer bio-distribution after cisterna magna injection at 30, 60, and 120 min.
[A-C] data indicated that tracer was firstly filled in SAS (t<30min), and subsequently
penetrated into brain along vasculatures. [D-F] details the magnified view of
vasculatures in the boxed in C. Data are representative of N=6 animals. Scale bar: [A,
B and C] 3 mm; [D, E and F]: 50 µm.

We then evaluated the exact location of the tracer in perivascular space. The
arteriole perivascular space consists of endothelial cells, pericytes, and smooth muscle
cells including basement membrane proteins that are ensheathed by astrocytic end-feet
from the brain side. The capillary perivascular space will contain all cellular components
like in arteriole but there is absence of smooth muscle cells. Co-localization of this tracer
with immunostaining of perivascular cellular markers indicated that the waste
metabolite tracer was found to be entrapped in between astrocytes (Figure 3.2A, GFAP)
particularly at the astrocytic end-feet (Figure 3.2 B & C) and vascular smooth muscle
cells (Figure 3.2D – G) as indicated by colocalization of alpha-SMA and tracer. I also
observed that the waste metabolite tracer did not readily cross the blood vessel but
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aggregated around perivasculature at early time point as shown in Figure 3.2E – G.
These observations seen in immunostaining colocalization studies were further
confirmed by multiphoton imaging techniques (Figure 3.2 H, H1, H2 & H3; Green:
FITC-d2000, CSF tracers; Red: Texas red-d70, label vasculatures).
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Figure 3.2 Co-localization of FITC-d2000 after cisterna magna injection with astrocyte
marker (GFAP) and vascular smooth muscle marker (alpha-SMA) revealed location of
tracers relative to vasculatures. [A]: Co-localization of tracer (FITC-d2000, 120 min
after cisterna magna injection) and astrocytes (GFAP). [B and C]: Detail views revealed
that tracers were wrapped by astrocytic end-feet (white arrows). [D] Co-localization of
tracer (FITC-d2000, 120 min after cisterna magna injection) and smooth muscle cells
(alpha-SMA). [E – G]: Detail views on right revealed that tracers were outside smooth
muscle layer, not in vessel lumen. [H]: Two-photon scanning of tracer bio-distribution
(Green: FITC-d2000; Red: Texas-Red d70). Animals were injected with two types of
tracers: FITC (green) was delivered through cisterna magna; Texas-Red (red) was
injected through tail vein to label vasculatures. 2 hours were allowed before sacrificing.
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[H] indicated location of vessel segments that presented in H1, H2 and H3. Data
suggested that after cisterna magna injection, tracers aggregated along vasculatures.
Data was representation of N=6 animals. Scale bar: [A and D]: 3 mm; [B and C]: 100
μm; [E, F and G]; [H]: 3 mm; [H1 and H2]: 50 µm; [H3]: 25 µm.

3.3.2 Intracranial Cortical Injection of FITC-d2000 Reaches the Perivascular
Space Prior to Subarachnoid Clearance Path
In contrast to deposition of waste metabolites directly into the CSF flow through cisterna
magna injection, we also injected a FITC-d2000 tracer directly into brain interstitial
space at the depth of 0.5 mm in the right cortical surface, 2.0 mm lateral to sagittal suture
and 3.0 mm away from caudal coronal suture at different time points. The rationale was
to determine if waste metabolites can diffuse directly into the perivascular space from
site of production (parenchyma) or the route of translocation would follow the path of
CSF flow via subarachnoid-paravascular clearance. We found that tracers started to
diffuse directly into para-and peri-vascular space from interstitial space after 60 min of
cortical injection, as indicated by Texas red-d70 labeled for vasculatures and FITCd2000 Green representing large size waste metabolites (Figure 3.3B – D). At this time
point, no tracers were detected at subarachnoid space through this route of injection
(Figure 3.3A), indicating that waste metabolites can move directly into PVS via the
interstitial diffusion. There was more accumulation of tracer in the perivascular space at
longer time points of 240 min (Figure 3.3E – F). This cumulative aggregation of tracer
in the PVS was from interstitial movement and dynamic translocation of CSF flow
because subarachnoid space was also filled with tracer at this later time point. Colocalization of tracer and vascular smooth muscle marker (alpha-SMA) immunostaining
revealed that most of the tracer was arterial and capillary structures (Figure 3.3G – H).
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Figure 3.3 Intracortical deposition of FITC-d2000 (green) directly into cortex (0.5 mm
below cortical surface) allow us to track the time-dependent diffusion of tracer along the
perivascular space marked by vessel marker Texas-Red d70 injected through the tail
vein. 45 µm brain slices on glass slides were subjected to fluorescence microscope. [A,
B, and E] indicate the time-dependent location of tracer. Small traces of tracers were
already translocated from site of injection to the perivascular space before reaching to
CSF, indicated by the absence of fluorescence in SAS. More tracers were found to move
at longer time (E). Detail view in [C, D, F] suggested that the accumulation of tracers at
PVS. [G and H]: co-localization of tracer (green) with smooth muscle actin (red)
indicated that these vessels were arterials due to the presence of smooth muscle cell.
Data are representative of N=6 animals. Scale bar: A: 1 mm; B and E: 300 µm; C, D, F
and G: 50 µm; H, I and J: 30 µm.

3.3.3 Evaluation of the Putative Mechanisms of Tracer Movement Towards
Perivascular Space
We then evaluated the putative mechanism of dynamic waste metabolites movement
towards PVS that could be associated with clearance path. Based on previous findings
[23, 28, 66, 73], we rationalized that increase in arterial vessel dilative reactivity by lowdose alcohol may regulate the movement of waste metabolites towards PVS. The
justification was that low dose alcohol was known to enhance vessel dilation through
nitric oxide (NO) production in endothelial cells [74]. As such, we first established the
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dose-response of ethanol concentrations from 2 – 10 mM on the tracer movement from
CSF to perivascular space. We determined 5 mM ethanol gave the maximal
biodistribution of tracer and this optimal working concentration is approximately
equivalent of 0.02% blood alcohol level, which is about 4 – 5 times lower than the legal
limit of 0.08 – 1.0% blood alcohol level. We observed that low dose of 5 mM ethanol
injection into rat via the tail significantly (p<0.05) enhanced the movement of the 2000
kDa FITC tracer from CSF to PVS compared with control (Figure 3.4A). Three
different regions of brain slices were selected according to rat brain atlas map (Figure
3.4A), and we observed a similar trend of increased distribution of tracer by ethanol in
all the three different brain regions. However, this stimulating effect of ethanol was
reversed by nitric oxide synthase inhibitor L-NAME, indicating that low dose ethanol
increased the movement of tracer through NOS mediated NO production.
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Figure 3.4 [A] Bio-distribution of tracer at 2 hours after cisterna magna injection in
control, 5 mM EtOH, and L-NAME + 5 mM EtOH. Coordination of brain coronal tissue
slices (45 µm) are shown according to rat brain map in three different locations, where
bio-distribution of tracer was imaged in the whole brain section. Scale bar: 2 mm. [B]
The quantity of tracer distribution in brain was calculated as mean fluorescence intensity
on each slide (from N=6 animals, 10~15 slices were taken from each animal, +SEM).
Data indicated that alcohol significantly increased the biodistribution of tracer and
vascular reactivity, while NOS inhibitor L-NAME reversed the effect compared with
control (*p<0.05).

Thus, among all isoforms of NOS, we evaluated the effects of 5.0 mM ethanol on
qualitative and quantitative levels of endothelial specific eNOS, and subsequent
production of NO levels in brain tissues. This biological marker was examined to
validate the idea that low dose ethanol enhanced the movement of waste metabolites
along the perivasculature through NO induced vessel dilative pathway. Interestingly,
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immunostaining revealed a huge increase of eNOS induction by low dose alcohol group
(Figure 3.5A), which was further validated by significant elevation of eNOS levels by
ethanol compared with control (p<0.05), as determined by Western blot analysis (Figure
3.5B). To correlate the low dose ethanol-induced eNOS activation with NO generation,
we analyzed the real-time NO production in live rat brain tissue by Free Radical
Analyzer (World Precision Instruments, Sarasota, FL) using a micro-sensor detector. In
line with eNOS activation, low dose alcohol exposure significantly elevated the
production of NO in rat brain compared with baseline (Figure 3.5C). As expected, cotreatment of L-NAME not only inhibited the induction of eNOS but also the production
NO level. These data collectively suggest that low dose alcohol can promote
perivascular clearance of waste metabolites through eNOS-mediated NO production by
increasing the cerebral arterial vessel dilations.
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Figure 3.5 Induction of eNOS by low dose ethanol produces endothelial derived nitric
oxide. [A] Left: Colocalization of eNOS (red) and tracer (green) in whole brain tissue
slice. Right: detailed view in boxed area. Data indicated that eNOS was elevated by
EtOH. (N=6 animals, 10~15 slices per animal). Scale bar: Left: 3mm; Right: 50 µm. [B
and C] The quantity of tracer distribution in brain was calculated as mean fluorescence
intensity on each slide (from N=6 animals, 10~15 slices were taken from each animal,
+SEM). Fluorescence intensity quantification of eNOS was calculated as mean
fluorescence intensity on each slide (from N=6 animals, 10~15 slices were taken from
each animal, +SEM) and presented as bar graphs for both whole brain scanning [B] and
arterial vessel cross-section [C]. Data indicated that both quantification showed
statistically significance upregulation of eNOS by low dose EtOH. Magnitude of
increase in eNOS levels in the whole brain area quantification is similar to that of
Western blot analyses. Whereas, the fold increase in arterial vessel is much higher than
that of whole brain or Western blot because localization of eNOS is specific to arterial
endothelium. [D] Western blot analysis of eNOS levels in different experiment
conditions. Data was analyzed using image J to obtain arbitrary densitometry intensity
units. Three replicates were done for each animal sample from N=6 animals. Bar graphs
data were quantified from the ratio of eNOS to that of β-actin bands, and expressed as
mean ±SEM. [E] Real-time NO production in live rat brain tissue (1 mm) by Free
Radical Analyzer, where NO production was simultaneously monitored. Bar graphs
show the average NO concentration under each condition, and expressed as mean
±SEM. The asterisk indicates the statistical significance (*p<0.05) in EtOH compare
with control.
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3.3.4 Low Dose Alcohol Enhances Dynamic Vessel Dilation
To validate the proof-of-concept that ethanol-induced arterial vessel reactivity promotes
the pool of waste metabolites along the PVS, we determined dynamic dilative vessel
reactivity by multiphoton imaging in live animals. We found that low dose alcohol
significantly increased tracer movement towards PVS within 15 min, where the flux of
tracer could be detected easily in the depth of 50 – 100 µm below cortical surface
(Figure 3.6A). This increase in tracer accumulation in the PVS in the presence of
alcohol was further supported by a significant vessel dilation (Figure 3.6B - C) and a
significant increase in arterial vessel diameter (Figure 3.6D) as revealed by two photon
line scan. This alcohol-induced significant increase in arterial vessel dilation and
contraction suggest the active interaction between brain endothelial cell and smooth
muscle cell within the arterial cellular components via the signaling molecule eNOSelicited NO production. Such a cross-talk between endothelial cell and smooth muscle
cell is unlikely to occur in the capillary since smooth muscle cells are absent in the
capillary.
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Figure 3.6 Low dose alcohol enhances dynamic vessel dilation: [A] Time-lapse in-vivo
two-photon imaging of florescent tracer (green, injected via intracisterna) and vessel
marker Texas-Red (injected via tail vein) showed the time-dependent aggregation of
tracer in perivascular space in 50-100 µm below cortical surface. [B] Dynamic imaging
of changes in vessel diameter over time (N=3) before and after exposure to 5 mM ethanol
at different time lapse. [C] Left: Cerebral was visualization of cerebral vasculature by
two-photon imaging after intravenous tail vein injection of Texas Red-d70 showing
penetrating arteriole in box (25 µm in diameter). Right: Selected area for X-T line scan
to examine the changes in vessel dimeter, which was analyzed by customized Matlab at
different time lapse. [D] Calculated changes in vessel dimeter, wherein baseline was
collected before alcohol exposure. A 9000 ms epoch line scan was applied every 15
minutes to determine the changes in vessel diameter, which is shown in bar graphs. Twoway ANOVA with tukey’s post-hoc test show the statistical significance * p<0.05
compared with baseline, expressed as mean ±SEM, N=3.

We then examined the idea that generation of the alcohol-induced vasodilator NO
from brain endothelial cells can readily diffuse into the underlining smooth muscle cells
(SMCs) reactivity. The rationale is that elevation of physiological NO levels in
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endothelial cell augments the endothelial-SMCs interaction to increase arterial vessel
dilation. The qualitative data from immunostaining staining of α-SMCs showed an
increase reactivity in low dose alcohol group compared with controls (Figure 3.7A),
which was in agreement with alcohol-induced NO production by endothelial cells. In
parallel with an increase α-SMCs expression, the quantitative assay by Western blot
analysis validated the significant elevation of α-SMCs levels in alcohol condition
compared with controls (Figure 3.7B). This data suggests an active interaction between
vascular endothelial cells (ECs) and smooth muscle cells through a paracrine signaling
pathway in which ECs derived nitric oxide acts as the key signaling molecular
messenger for vessel dilation. The underlying mechanism of ECs-SMCs interaction
through NO will be thoroughly discussed in next chapter.
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Figure 3.7 [A] Shows the representative expression of brain vascular α-smooth muscle
actin (αSMA, red) in whole brain tissue sections (10 µm thick) in different experiment
conditions with a significant increase by ethanol exposure (N=6 animals, 10~15 slices
per animal). Scale bar: 30 μm. [B] Western blot analysis of αSMA levels in different
experiment conditions. Data was analyzed by image J to obtain arbitrary densitometry
intensity units. Three replicates were done for each animal per condition. Bar graphs
show the quantified data that were expressed as ratio of αSMA immunoreactive bands
to that of β-actin bands, with mean ±SEM. * indicates the statistical significance p<0.05
compared with control or L-NAME+EtOH/L-NAME alone.

3.3.5 Vessel Dilation Increases Waste Metabolite Clearance
So far, we have shown that large size waste metabolites that are not able to diffuse across
the subarachnoid (SA)-superior interface (due to the presence of SA microvilli) in CSF
flow get accumulated in perivascular space in the presence of low dose alcohol. This
includes the interstitial-perivascular movement of waste metabolites. The diffusion of
these metabolites towards the perivascular space appeared to be regulated by alcohol
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mediated increase in arterial vessel contraction and dilation. We then examined whether
these accumulated waste metabolites at the perivascular space will diffuse into the
perivenous space across the bed of capillaries, and get exchange/efflux into the blood
circulation as clearance mechanisms. The results clearly showed an increase
colocalization of the 2000 kDa FITC tracer and venule marker (endomucin) in alcohol
group (Figure 3.8A – B) compared with controls (Figure 3.8C – D), even though the
tracer aggregation in perivenous space was not as high as in perivascular space. This
data suggests a limited exchange of metabolites from perivascular space to perivenous
space, which indicates efflux of metabolites from perivascular/perivenous space into the
blood circulation.
This led us to examine validation of tracer in blood plasma samples from different
experimental conditions as a proof-of-concept. Blood samples were collected at the time
of sacrifice from different experimental groups with/without L-NAME injection, and
separated the plasma. The 2000 kDa FITC tracer in blood plasma samples was detected
by SpectraMax Multi-Mode fluorescence microplate reader at the specific excitation
(490 nm) and emission (525 nm) wavelengths. We observed a significant increase of
tracer fluorescence intensity in the plasma samples in low dose alcohol group compared
with controls or the alcohol plus L-NAME group (Figure 3.8E), indicating that low dose
alcohol promotes the waste metabolites clearance path from perivascular/perivenous
space into the blood circulation. These findings suggest the existence of large size waste
metabolites clearance path from perivascular or perivenous space into the blood
circulation, which is regulated by alcohol-induced NO mediated cerebral vessel dilation.
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Figure 3.8 Validating the diffusive exchange of waste metabolite from perivascular to
perivenous space (at the bed of capillaries). [A - D] Colocalization of FITC tracer
(Green) and venule marker endomucin (red) in alcohol group (A&B) compared with
control (C&D), indicating an exchange of large size metabolites from perivascular space
to perivenous space. Scale bar: 30 μm. [E] Detection of FITC-d2000 in blood plasma
collected after 120 min cisterna magna injection from different experiment conditions,
(n=6/per group, + SEM). One-way ANOVA and post-hoc turkey test (* p<0.05,
compared with control) was performed to compare difference between each group.
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3.4 Discussion
We discuss the findings that large size waste metabolites in the brain that are unable to
clear out by the conventional CSF clearance path get diffused towards perivascularperivenous space from the interstitial fluid and from the CSF-subarachnoid flow. Thus,
there is a dynamic movement of large size waste metabolites from interstitial space and
subarachnoid towards perivascular space under normal physiological condition. To
mimic those large size waste metabolites, we used a relative large molecular weight
fluorescent tracer (2000 KD) and administered into brain. The rationale is that due to
the molecular size limitation and also shown by other study [29], after injection into
brain tracers tended to accumulate at perivascular space instead of being eliminated
through typical clearance routes including BBB trans-vascular clearance, degradation
and CSF/ISF diffusion as noted in publication [66]. This physiological behavior is
comparable with what have been observed in certain neurological diseases including
perivascular phosphorylated tau protein disposition in cerebral amyloid angiopathy
(CAA) and aggregated amyloid beta protein in Alzheimer’s disease [75, 76]. To validate
the use of tracers, we also showed that the tracers used in the study revealed similar
movement pattern as A-β proteins following differnet injection routes (Figures D.1 and
D.2). Thus, though differed from chemical composition, given the physiology similarity
of tracers and large size waste metabolites in brain as discussed, the movement pattern
of tracer was considered informative towards current study purpose.
We firstly showed the perivascular disposition phenomenon by the bio-distribution
of large size molecular weight fluorescent tracer injection from two different routes, a
direct deposition of tracer into the CSF flow by intracisterna magna injection and a direct
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deposit of tracer into interstitial space through intracranial cortical route. Even though
the subarachnoid (SAS) was filled with fluorescence tracer within 30 min, the actual
penetration of tracer into the perivascular space occurred after 60 minute in intracistertna
magna injection (Figure 3.1A-F). In the interstitial cortical injection, the tracer diffused
directly into perivascular space within 60 min (Figure 3.3A-D), while the CSF flow was
filled with tracer at the much later time points (Figure 3.3E-F), indicating the slow
clearance of large size waste metabolite from interstitial fluid to C3 choroid flexus.
These data suggest that waste metabolites can diffuse directly into PVS timedependently from interstitial fluid and from CSF-subarachnoid flow, which is regulated
by endothelial-smooth muscle cell dilation. Similar alternative clearance mechanisms of
direct translocation of interstitial solutes to perivascular space have been proposed in
mouse model [28].
Intriguingly, the data showed that a very low level of 5.0 mM ethanol, equivalent
of 0.02% blood alcohol level can enhance the dynamic movement pattern of these waste
metabolites towards perivascular-perivenous space. This concentration is far below the
legal limit of 0.08 % blood alcohol level. In spite of alcohol being an addictive
substance, the low-dose of this legalized substance is likely to improve the clearance of
waste metabolites in the brain. Thereby, one drink of alcohol a day may ameliorate the
progression of many neurological diseases that are originated from toxicity of nonclearance waste metabolites. Interestingly, a number of recent population-based cohort
studies concluded that heavy alcohol use in chronic condition is associated with
development dementia and progression of Alzheimer’s disease and cerebral amyloid
angiopathy [77-84], the hallmark of these neurological diseases happen to be the
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deposition of waste metabolites like A-β protein, or protein prion-like proteinopathies
around the perivascular space [1, 2, 48]. These cohort studies also unequivocally noted
the protective effects of low dose alcohol use against the progression of dementia and
AD/CAA, with unknown mechanisms. It is apparent that beneficial or destructive effects
of alcohol is dependent on the duration and concentration use. In the present studies, we
use low level of alcohol to understand the protective mechanisms for promoting
perivascular clearance because low-moderate alcohol use is protective of vascular and
cardiovascular function [4, 64, 65, 85-87]. We also showed that use of alcohol
concentrations that are between 2.5 mM - 20 mM (~ 0.08%) revealed comparable effects
in terms of PVS clearance (Figure E.1). The likely reason can be attributed to the
findings that these alchol concentrations are adequately to stimulate eNOS expression
and NO release (Figure E.2), which regulated the PVS clearance efficiency. In addition,
repetitive intake of low dose alcohol (5 mM) showed similar effect (Figure E.3), which
lined up with the beneficial effect of low dose alcohol intake.
We noted here that the contrast effects of low dose alcohol intake and chronic use
of high dose alcohol (equivalent of alcohol dependent subjects) in the context of bloodbrain barrier permeability and perivascular clearance path will be discussed in the
following chapters.
We then addressed the underlying clearance mechanisms of the accumulated waste
metabolites from perivascular or perivenous space into the blood circulation by two
approaches. The exchange of waste metabolites from perivascular space to perivenous
space across the bed of capillaries, and detection of waste metabolite in blood samples
collected from jugular vein. Colocalization of tracer with venule marker clearly showed

57

a significant accumulation of tracer in perivenous space of alcohol group compared with
controls (Figure 3.8A-D), however the tracer intensity was less than that of perivascular
space (Figure 3.6A). These results indicated the movement of metabolites from
perivascular to perivenous space across the bed of capillary. The exchange of waste
metabolites from perivascular/perivenous space into the blood circulation as the
clearance path was examined by the presence of fluorescent tracer in blood plasma
samples from various experimental conditions. A significant detection of tracer in the
plasma samples in low dose alcohol group was markedly higher than controls or alcohol
plus NOS inhibitor L-NAME groups (Figure 3.8E). These data suggest that the tracer
was leaked into the circulation from perivascular/perivenous exchange because this
large size waste metabolite was not permeable from subarachnoid to sagittal sinuses due
to blockade by subarachnoid microvilli. The significantly low level of tracer present in
NOS inhibitor plus alcohol group also suggested the direct role of alcohol-induced NO
elicited perivascular/perivenous-blood circulation clearance path.
We then validated the underlying mechanisms that alcohol-elicited eNOS specific
NO production promoted the cerebral arterial vessel dilation and clearance. The
rationale was that NO production augmented the endothelial-smooth muscle cell
reactive interactions and arterial vessel dilation. This is because low dose alcohol
consumption led to an increase eNOS activity and NO production [4, 64, 65], whereas
high dose chronic alcohol consumption led to detrimental consequences on vascular
function [67, 88, 89]. In support of our hypothesis, we observed an increase reactivity
of α-SMCs in low dose alcohol qualitatively and quantitative compared with controls or
in the presence of NOS inhibitor (Figure 3.7A-B). The observations were in line with

58

the findings that NO-mediated endothelial-smooth muscle cells interaction was key to
arterial vessel reactive dilation [90, 91], and perhaps the movement of tracer along PVS
[73]. The rationale is that endothelial-derived NO generation can diffuse readily into the
underlying SMCs and cause vessel dilation through a cascade of paracrine-mediated
biochemical signaling events [90, 91], wherein NO serves as the key signaling molecule
for vessel dilation.
Apart from local level regulation of vessel dilation including response to
mechanical forces (e.g., shear stress) and chemical stimuli (e.g., NO) as discussed above,
it was also known that vessel contraction/dilation was neural activity dependent and
increased vessel dilation was coupled sensory stimulus. For example, using whisker
stimulation and cortical spreading depolarization, researchers observed microvascular
diameter changes in smooth muscle covered microvessels in brain [63]. However, due
to the study scope limitation, the current research focus was primarily on the local level
regulation of regional blood vessel dilation that exerted by low dose alcohol. Brain
activity dependent regulation was not discussed in this dissertation.
In conclusion, the diffusive movement of large size waste metabolites from
interstitial fluid and from CSF-subarachnoid flow into perivascular-perivenous drainage
path is regulated by reactive dilation of endothelial-smooth muscle cells. We found that
low dose alcohol can significantly promote these waste metabolites movement towards
the perivascular-perivenous space and its clearance into the circulation. We confirmed
that alcohol-elicited eNOS specific NO production regulated the cerebral arterial vessel
dilation through endothelial-smooth muscle cell reactive interactions (Figure 3.9). The
present findings are expected to have far-reaching translational significance, particularly
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the timely clearance of entangled proteins in neurological diseases.

Figure 3.9 Illustration of alcohol promotes waste metabolites clearance. (A) Arrows
(orange) indicate the CSF subarachnoid flow and perivascular-perivenous clearance
path (black) of large size waste metabolites (red dots) in neurodegenerative brain. Waste
metabolites like β-amyloid proteins are aggregated more inside the interstitial space due
to the lack of lymphatic system in the brain. Less metabolite are drained into the CSF
flows due to less vessel dilative reactivity. (B) Neurodegenerative brain in the presence
of low dose alcohol. Dilative arterial vessel reactivity promotes the dynamic movement
of large size waste metabolites from interstitial fluid to perivascular space and from
interstitial-CSF subarachnoid to perivascular space. Reactivity of endothelial and
smooth muscle cells in arteries is mediated by alcohol-elicited eNOS activation and NO
production.
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CHAPTER 4
MECHANISM OF ALCOHOL MEDIATED SMCs-ECs INTERACTION

4.1 Summary
We have shown that alcohol-mediated vasodilation can exert beneficial effects towards
brain waste metabolites clearance through induction of endothelial function and
enhancement of neighboring smooth muscle reactivity from previous chpater. Here in
this chapter, we further investigated the underlying mechanism of ECs-SMCs
interaction by addressing the response of endothelial cells to low dose alcohol and
examining level of NO releasing and corresponding enzymes expression. We
determined the activities of surrounding smooth muscle cells by evaluating the
phosphorylation status of myosin light chain (MLC) and activities of corresponding
regulatory subunits. Results indicated that low level alcohol promotes NO release from
endothelial cells through eNOS. NO induced smooth muscle relaxation occured through
myosin

light

chain

dephosphorylation.

Regulation

of

NO-mediated

MLC

dephosphorylation was done via the paradigm shift from myosin light chain kinase to
myosin phosphatase activities. We validated such observations by qualitative
immunostaining and quantitative Western blot analyses. Collectively, we showed that
alcohol induced arterial vessel dilation was via eNOS mediated NO generation in ECs,
which rapidly diffused into neighboring SMCs and caused MLC dephosphorylation
through interplay of myosin light chain kinase and myosin phosphatase activities.
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4.2 Background
Low-to-moderate consumption of alcohol is known to exert protective effect towards
biological vascular system. Intriguingly, consistent epidemiologic evidence has pointed
to an inversely association between moderate alcohol consumption and vascular disease
[86, 87, 92]. For example, human studies revealed a 20 – 40 % reduction of
cardiovascular disease among drinkers of alcoholic beverages compared with nondrinkers [93]. However, the underlying mechanism of such effect is still under debate.
Some researchers claimed that beverage choice among wine, beer and liquor may
bear more relevance and they supported a preferential red wine protective effect that
partly attributes to the polyphenolic antioxidant content [94]. This hypothesis was
initiated by a report known as the ‘French Paradox’ that describes the low vascular
disease and mortality ratio of the French population despite their high dietary intake of
saturated fats, a phenomenon accredited to consumption of red wine due to its active
composites, including resveratrol and other polyphenolic agents [95-97]. To support
this point of view, several animal studies have focused on polyphenol vascular effects
and revealed that wine polyphenols showed antioxidant, anti-inflammatory, hypotensive
and anti-platelet aggregation actions [98-101]. In a human study, researchers showed
that intaking of dealcoholized red wine at 1-week intervals significantly increased
plasma antioxidants, indicating the strong antioxidant potential of wine polyphenols
[102].
On the contrary, other studies showed that equal effects of alcohol beverage were
observed on vascular disease risk and the content of ethanol and its subsequent
metabolites acted as active protective agents [103]. For example, alcohol is known to
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elicit nitic oxide (NO) generation in vivo through vascular endothelial function [74].
Researchers found that low dose alcohol improved vascular endothelial function through
increasing endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO)
production [74]. Loading low dose alcohol to certain cell types (e.g., human umbilical
vein endothelial cells, bovine aortic endothelial cells) promoted NO production, eNOS
protein expression [64, 104, 105] and corresponding mRNAs expression [65]. Similar
phenomenon was observed in animal studies in which low dose ethanol consumption in
rats increased nitric oxide production and eNOS expression in the aortic vascular wall
[106]. Taken that NO can serve as a signaling molecule that regulates vascular dilative
activity, studies have shown that low dose alcohol exertes a protective effect towards
vasculatures through NO mediated vessels dilation. In vivo, animal studies have shown
that acute low dose EtOH increases release of NO, augments endothelium-mediated
vasodilatation [106-108] and decreases mean blood pressure [106]. In a human
multiethnic study, drinkers (between 1 drink/month and 2 drinks/day) were more likely
to have a higher flow-mediated dilation (FMD) than non-drinkers and those who drank
>2 drinks/day, independently of the type of alcoholic beverage consumed [109].
In a previous study [62], we showed that low dose alcohol-elicited NO production
promoted large size brain waste metabolites clearance by enhancing interaction of
vascular endothelial cells (EC) and smooth muscle cells (SMC). But the mechanism
underlying ECs-SMCs interactive cross-talk was not yet fully understood yet. Here, we
investigated the idea that alcohol-elicited NO from ECs can immediately diffuse into
neighboring SMCs, subsequently cause relaxation of myosin light chain (MLC) in SMC,
and ultimately induce vasodilation. The rationale is that the contractility of smooth
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muscle cell is controlled by a cellular component known as myosin light chain (MLC)
and NO has been shown to actively engage in regulation of MLC regulatory subunits
[110].
4.3 Results
In this chapter, we examined the idea that low dose alcohol mediated arterial vessel
dilation was done through interaction of vascular ECs and SMCs whereby NO generated
from ECs rapidly diffused into neighboring SMCs and subsequently caused SMC
relaxation. To verify this idea, we firstly determined the response of ECs to low dose
alcohol by examining NO generation and enzyme expression. Then we investigated how
SMCs react to NO focusing on myosin light chain phosphorylation level and
corresponding enzymes activities. The underlying mechanism of alcohol mediated
arterial vessel dilation was supported by these findings.
4.3.1 Alcohol below 20 mM Has no Toxic Effect on ECs and SMCs
We first focused on the toxicity effect of different alcohol concentration on the coculture system of two cell types: ECs and SMCs. The two cell types were mixed at 1:1
ratio and directly in contact with each other to mimic in vivo vascular structures.
Corresponding cellular protein markers (vWF for ECs and SMA for SMCs) were
evaluated to verify the co-existence (Figure 4.1A and B). A Serial concentration of
alcohol was used to determine the toxicity as shown in the graph. Noted that the highest
dose I used was 20 mM, which is approximately equivalent to the legalized blood
alcohol level (~0.08%). I found that after incubating with alcohol at given concentrations
for 2 hrs, no significant cell survival difference was observed among alcohol treatments
compared with control (Figure 4.1C), indicating that alcohol concentration less than 20
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mM have no toxic effect on ECs and SMCs, which is consistent with previous report
[72].

Figure 4.1 Cell toxicity evaluation. Various doses of alcohol were loaded to endothelial
– smooth muscle cells co-culture system. Two hours were given before proceeding to
MTT assay. [A and B]. Immunoreactive bands of vWF (endothelial cell markers), SMA
(smooth muscle cell markers) and β-actin, and quantitative corresponding protein
content in different experimental groups. Results were expressed as the ratio of protein
of interest to that of actin bands and presented as mean values (± SEM). [C]. Cell toxicity
assay by MTT showed viability with variable concentrations of alcohol represented by
plot. Results were expressed as the ratio of OD value of each experimental condition to
that of control and presented as mean values (± SEM). *Statistically significant (p <
0.05) compared with controls. Three replicates were done for each sample from at least
N=3 cultures.

4.3.2 Alcohol Promotes NO Release from ECs through eNOS not iNOS
Next, we proceeded to investigate the response of ECs to alcohol (10 mM). The optimal
alcohol concentration was determined from a dose-dependent study. We analyzed the
real-time NO production in ECs by Free Radical Analyzer using a micro-sensor detector
and found that alcohol exposure significantly elevated release of NO in ECs compared
with baseline (Figure 4.2A and B). Moreover, we observed a time-dependent increase
of NO production by checking different time intervals. This can be justified by the fact
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that NO generation depends on corresponding enzymes induction.

Figure 4.2 Real-time NO production in cultured endothelial cells in the presence of 10
mM EtOH. 50 µM L-NAME pre-treated tissue for 30 min as baseline. Medium
containing 10 mM EtOH was supplied subsequently. [A]. Functional output from free
radical analyzer. Graph denotes the current signal (pA) change (proportional to NO
concentration) captured by the NO sensor during each data collection interval, which
was marked by blue vertical lines. [B]. Bar graph was plotted as the ratio of signal
readout of each acquisition interval to that of baseline and presented as mean values (±
SEM). Statistically significant (*p < 0.05, ***p<0.001) compared with controls. Three
replicates were done for each sample from at least N=3 cultures.

We then evaluated the induction of NO generation enzymes, eNOS and iNOS to
correlate with NO release. Interestingly, immunostaining revealed a huge increase of
eNOS induced by alcohol and not surprisingly the effect was neutralized by inhibitor
(L-NAME) (Figure 4.3A), which was further validated by significant elevation of eNOS
levels by ethanol compared with control (p<0.05), as determined by Western blot
analyses (Figure 4.3B). On the contrary, no significant change of iNOS was found in
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alcohol group compared with control by both immunostaining and western blot (Figure
4.4A and B), indicating that NO release can be mainly accredited to eNOS but not iNOS.
This can be explained by the idea that elevation of physiological NO levels in endothelial
cells through eNOS augments vascular function whereas iNOS mediates massive NO
production associated with free radical generation, which exerts detrimental effect
towards surrounding tissues [72, 111]. Further examination of nitrosative stress marker,
3-nitrotyrosine (3-NT) expression across groups showed no significant difference
(Figure 4.5A and B), supporting this justification.

Figure 4.3 EtOH induces eNOS protein expression in endothelial cells. [A].
Immunostaining of eNOS (green) and vWF (red) protein in control, EtOH (10 mM), LNAME + EtOH and L-NAME. eNOS and vWF were used as primary antibodies
(information in Table 2.1). Alexa Fluor 488/594 were used as corresponding secondary
antibodies. Data representats at least N=3 cultures per each group. Scale bar: 30 μm.
[B]. Immunoreactive bands of eNOS and β-actin, and quantitative corresponding protein
content among experimental groups. Results were expressed as the ratio of protein of
interest to that of actin bands and presented as mean values (± SEM). *Statistically
significant (p < 0.05) compared with controls. Three replicates were done for each
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sample from at least N=3 cultures.

Figure 4.4 No difference of iNOS protein expression in endothelial cells under different
experimental conditions. [A]. Immunostaining of iNOS (green) and vWF (red) protein
in control, EtOH (10 mM), L-NAME + EtOH and L-NAME. iNOS and vWF were used
as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were used as
corresponding secondary antibodies. Data represents at least N=3 cultures per each
group. Scale bar: 30 μm. [B]. Immunoreactive bands of iNOS and β-actin, and
quantitative corresponding protein content among experimental groups. Results were
expressed as the ratio of protein of interest to that of actin bands and presented as mean
values (± SEM). No statistically significant (p < 0.05) difference compared with
controls. Three replicates were done for each sample from at least N=3 cultures.
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Figure 4.5 No difference of nitrosative marker, 3-nitrotyrosine expression in endothelial
cells under different experimental conditions. [A]. Immunostaining of 3-NT (green) and
vWF (red) protein in control, EtOH (10 mM), L-NAME + EtOH and L-NAME. 3-NT
and vWF were used as primary antibodies (information in Table 2.1). Alexa Fluor
488/594 were used as corresponding secondary antibodies. Data was representation of
at least N=3 cultures per each group. Scale bar: 30 μm. [B]. Immunoreactive bands of
3-NT and β-actin, and quantitative corresponding protein content among experimental
groups. Results were expressed as the ratio of protein of interest to that of actin bands
and presented as mean values (± SEM). No statistically significant (p < 0.05) difference
compared with controls. Three replicates were done for each sample from at least N=3
cultures.

4.3.3 NO by Donor SNAP (15 µM ) Not Induces Free Radical Damage in SMCs
To precisely investigate the effect of NO on SMCs, we also exposed cells directly to NO
through the NO donor, SNAP (S-nitroso-N-acetylpenicillamine). NO is a highly active
molecule that in the presence of O2, can react with O2− to form peroxynitrite (ONOO−),
a potent oxidizing agent that can lead to cytotoxicity by nitrating and hydroxylating
aromatic compounds, including guanosine and tyrosine (nitrotyrosine) [74, 112]. To
avoid such deleterious effects, we tried to limit the amount of NO using but still
adequately for experimental purposes. Therefore, we conducted a dose-dependent assay
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(10 – 100 µM) and found that concentrations less than 20 µM did not induce noticeable
nitrosative stress on SMCs, which agrees with a previous paper [72]. Among all
concentrations, we found that 15 µM yielded best results for NO supply (Figure 4.6A
and B) without significant free radicals damage (Figure 4.7A and B) and thus, was
determined as the working dose.

Figure 4.6 Real-time NO level in cultured SMCs in the presence of 15 µM SNAP.
Cells were pre-treated with 50 µM L-NAME for 30 min as baseline. Medium containing
15 µM SNAP was supplied subsequently. [A]. Functional output from free radical
analyzer. Graph denotes the current signal (pA) change (proportional to NO
concentration) captured by the NO sensor during each data collection interval, which
was marked by blue vertical lines. [B]. Bar graph was plotted as the ratio of signal
readout of each acquisition interval to that of baseline and presented as mean values (±
SEM). Statistically significant (*p < 0.05, ***p<0.001) compared with controls. Three
replicates were done for each sample from at least N=3 cultures.
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Figure 4.7 Nitrosative marker, 3-nitrotyrosine expression in cultured SMCs in the
presence of 15 µM SNAP. [A]. Immunostaining of 3-NT (green) and SMA (red) protein
in control and SNAP (15 µM SNAP). 3-NT and SMA were used as primary antibodies
(information in Table 2.1). Alexa Fluor 488/594 were used as corresponding secondary
antibodies. Data represents at least N=3 cultures per each group. Scale bar: 300 μm. [B].
Immunoreactive bands of 3-NT and β-actin, and quantitative corresponding protein
content among experimental groups. Results were expressed as the ratio of protein of
interest to that of actin bands and presented as mean values (± SEM). Statistically
significant (p < 0.05) compared with controls showed no difference. Three replicates
were done for each sample from at least N=3 cultures.

4.3.4 Alcohol Induced Smooth Muscle Relaxation Was through Myosin Light
Chain Dephosphorylation
Next, we evaluated the mechanism of alcohol-elicited-NO from ECs induced smooth
muscle relaxation by checking phosphorylation levels of myosin light chain (MLC). The
phosphorylation of the 20-kDa myosin regulatory light chains (MLC) is the primary
determinant of cross-bridge attachment and cycling during contraction and relaxation in
smooth muscle [113]. In brief, phosphorylation of MLC leads to SMC contraction while
dephosphorylation yields relaxation. Using specific antibodies that can detect
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phosphorylation of MLC at Ser19/20 in smooth muscle cells, we found that compared
with control, alcohol-induced-NO from ECs significantly diminished phosphorylation
levels of MLC at Ser19/20 in SMCs and, in parallel quantitative assay western blot
validated this finding (Figure 4.8A and B). The positive control from NO (SNAP)
supported this finding. Since dephosphorylation of MLC suggests relaxation of SMC,
the data indicates that alcohol-induced-NO-caused SMC relaxation was through
dephosphorylation of MLC at Ser19/20.
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Figure 4.8 Phospho-myosin light chain (Ser19/20) level in cultured ECs-SMCs in the
presence of 10 mM EtOH and15 µM SNAP. [A and B]. Immunostaining of SMA (green)
and phosphor-MLC protein in control, low dose alcohol and SNAP (15 µM; NO donor
as positive control). SMA and smooth muscle specific phosphor-MLC(Ser19/20) were
used as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were used
as corresponding secondary antibodies. Data represents at least N=3 cultures per each
group. Scale bar: 200 μm. [B]. Immunoreactive bands of phosphor-MLC (Ser20) and βactin, and quantitative corresponding protein content among experimental groups.
Results were expressed as the ratio of protein of interest to that of actin bands and
presented as mean values (± SEM). *Statistically significant (p < 0.05) compared with
controls. Three replicates were done for each sample from at least N=3 cultures.
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4.3.5 Alcohol Induced MLC Dephosphorylation Was via Myosin Phosphatase
Activities
Further, we proceeded to investigate the underlying mechanism of alcohol-elicited-NO
mediated MLC dephosphorylation in the co-culture system. MLC phosphorylation level
was determined by the balance of the Ca2+ dependent myosin light chain kinase
(MLCK) and myosin light chain phosphatase (MLCP) activities. When MLCK was
activated by Ca2+ -calmodulin complex, it underwent posttranslational change,
phosphorylation to become active [114]. Whereas its counterpart, MLCP activity was
similarly regulated by phosphorylation mediated events but in a more complex way.
According to recent publications, phosphorylation of the MLCP regulation subunit,
myosin phosphatase target subunit 1 (MYPT1) at Ser618/668/692/695 residues can
increase MLCP activities while at Thr696/853 residues, led to inhibitory effects [110,
115, 116]. Thus, by employing antibodies that target specific phosphorylation residues
pertinent to each protein, we examined the activities of MLCK and MLCP in SMCs
under control, alcohol and SNAP (positive control) treatment. Interestingly, we found
that the phosphorylation level of MYPT1 at Ser618/668 in SMCs was significantly
increased by alcohol and NO (positive control) through immunostaining and western
blot (Figure 4.9A and B) assays, indicating that MLCP activities in SMCs were upregulated by alcohol-induced-NO from ECs. Meanwhile, the level of phospho-MLCK
at Ser 1760 was decreased under alcohol and NO treatment compared with control
(Figure 4.9C), suggesting a reduction of MLCK activities by alcohol-induced-NO from
ECs. Postitive control validated the role of NO in this process.
Collectively, the information that this data conveys is that alcohol-elicited-NO
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release from ECs is strongly correlated with MLCP/MLCK activities in SMCs: NO led
to elevation of MLCP activity but inhibition MLCK. When the entire system favored
more MLCP, MLC turned to be dephosphorylated and SMC manifested relaxation.

Figure 4.9 Phospho-MYPT1/2 (Ser618/688) and phosphor-MYLK (Ser1760) level in
cultured ECs-SMCs in the presence of 10 mM EtOH and 15 µM SNAP. [A].
Immunostaining of SMA (green) and phospho-MYPT1/2 (Ser618/688) (red) protein in
control, EtOH and SNAP (15 µM SNAP). SMA and phospho-MYPT1/2 (Ser618/688)
were used as primary antibodies (information in Table 2.1). Alexa Fluor 488/594 were
used as corresponding secondary antibodies. Data was representation of at least N=3
cultures per each group. Scale bar: 200 μm. [B and C]. Immunoreactive bands of [B]:
phospho-MYPT1/2 (Ser618/688), [C]: phosphor-MYLK (Ser1760) and β-actin, and
quantitative corresponding protein content among experimental groups. Results were
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expressed as the ratio of protein of interest to that of actin bands and presented as mean
values (± SEM). *Statistically significant (p < 0.05) compared with controls. Three
replicates were done for each sample from at least N=3 cultures.

4.4 Discussion
In the present study, we discuss the finding that alcohol, especially at low dose ingestion,
can promote arterial vessel dilation through enhancing interaction of vascular
endothelial cells and smooth muscle cells. Firstly, we evaluated the response of ECs
when exposed to low dose alcohol (10 mM) with focus on nitric oxide (NO) generation
and corresponding enzymes expression. We showed that alcohol, at given doses, can
increase NO releasing, which is mediated by elevation of eNOS expression instead of
iNOS. This phenomenon was consistent with previous observation in animal studies
[62] and can be justified by the difference between those two isomers in terms of NO
generation: eNOS augments physiological NO levels in endothelial cells that regulate
normal vascular function while iNOS is typically associated with free radical generation
like peroxynitrite, inducing surrounding tissue damage [72, 111]. Further evidence of
no over-expression of the nitrosative stress marker among groups (Figures 4.5A and B)
validates this explanation.
We then investigated the underlying mechanism of alcohol-elicited NO-mediated
relaxation of SMCs. Researches have shown that NO, known as an endotheliummediated vessel dilator, can regulate neighboring smooth muscle contractility [106108]. Smooth muscle cells, unlike skeletal and cardiac muscles, relied on
phosphorylation of the 20 KDa regulatory myosin light chain (MLC) at the Ser19
residue to exert contractile activities [110]. The regulation of phosphorylation extent
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was determined by the balance of the activities of two protein enzymes: myosin light
chain kinase (MLCK) and myosin light chain phosphatase (MLCP) [115]. We showed
that by treating cultured ECs-SMCs with alcohol and NO (positive control), the
phosphorylation level of MLC was significantly diminished compared with control and
that MLCP activities line up with MLC dephosphorylation levels whereas MLCK
activities are adversely correlated (Figures 4.8 and 4.9), indicating that alcohol-elicited
NO-caused SMCs relaxation was regulated by MLCP/MLCK mediated MLC
phosphorylation.
NO can activate soluble guanylate cyclase, thus augmenting cGMP. Elevated
cGMP presumably activates cGMP-dependent protein kinase (PKG) and hence induces
a variety of phosphorylation events. For instance, the phosphorylation of several
intracellular mechanisms by PKG results in a reduction in myoplasmic calcium [114,
117], which reduces engagement of calcium with calmodulin. Since formation of the
Calcium-Calmodulin complex is essential for MLCK activation, a reduction of proper
engagement will inevitably lead to decreasing MLCK activities and therefore
dephosphorylate MLC. Also, cGMP-PKG was found to directly involve in MLCP
regulation in several studies. For example, phosphorylation of Ser-695 at myosin
phosphatase target subunit 1 (MYPT1) by cGMP mediated PKG was found to activate
MLCP [110] and inhibition of NO mediated cGMP-PKG by NOS inhibitor (L-NAME)
showed a reduction of phosphorylation at S695/S668, which correlated with decreasing
MLCP activities [116].
Intriguingly, previously we reported that a very low level of 5.0 mM ethanol,
equivalent of 0.02% blood alcohol level, can enhance the dynamic movement pattern of
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large size waste metabolites towards the perivascular-perivenous space and the
underling mechanism was that alcohol-elicited eNOS specific NO production regulated
the cerebral arterial vessel dilation through endothelial-smooth muscle cell reactive
interactions [62]. The current research further addressed the mechanism we proposed
previously: alcohol induced arterial vessel dilation is via eNOS mediated NO generation
in ECs, which rapidly diffuse into neighboring SMCs and cause MLC
dephosphorylation through an interplay of myosin light chain kinase and myosin
phosphatase activity (Figure 4.10)

Figure 4.10 Schematic representation of alcohol mediated endothelial cells and smooth
muscle cells interaction. Alcohol can elicit eNOS expression and NO production in
endothelial cells. NO from endothelial cells rapidly diffuses into surrounding SMCs,
causing elevation of cGMP. cGMP mediated PKG pathway leads to myosin light chain
relax (de-phosphorylation) through: 1). up-regulation of myosin light chain phosphatase
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activities; 2) down-regulation of myosin light chain kinase activities.
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CHAPTER 5
CONTRAST EFFECTS OF LOW/ACUTE AND MODERATE/CHRONIC
ALCOHOL ON CNS WASTE METABOLITES CLEARANCE

In previous chapters, we have shown that low dose alcohol promotes perivascular
clearance of waste metabolites in the brain, which is regulated by dilative reactivity of
arterial smooth muscle cells and endothelial cells via the signaling molecule, NO. These
findings clearly indicate the importance of blood-brain barrier (BBB) transvascular
clearance of large size metabolites in the CNS, where the lymphatic clearance system is
absent. In this chapter, we examined the contrast effects of acute low dose and chronic
moderate alcohol intake on perivascular clearance of waste metabolites in the brain.

5.1 Summary
To evaluate the contrast effects of acute low dose and chronic moderate alcohol intake
on waste metabolites clearance in the brain, we injected a large size fluorescent dye
representing waste metabolites like A-β protein into the cerebrospinal fluid (CSF). Then,
we examined the bio-distribution of tracer towards perivascular space in different brain
regions by whole brain tissue section scanning. We found that the underlying molecular
and cellular mechanisms that drive the increase or decrease movement of tracer to
perivascular space by acute/chronic alcohol exposure correlated to BBB integrity and
arterial vessel reactivity. Accordingly, the contrast effects of alcohol appear to be
regulated by the switch mechanisms of endothelial specific nitric oxide synthase (eNOS)
activation by low dose and inducible NOS (iNOS) by moderately high alcohol exposure
in chronic conditions. We validated these observations by qualitative and quantitative
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data. As such, my conlusion is that low dose alcohol promotes the diffusive movement
of waste metabolites to perivascular clearance through eNOS-derived NO-regulated
arterial endothelial-smooth muscle cells dilative reactivity without affecting the integrity
of BBB. Whereas, continuous induction of iNOS in chronic alcohol exposure causes
oxidative damage of the arterial endothelial-smooth muscle layers that led to BBB
dysfunction, reducing dilative reactivity, and decreasing movement of waste metabolites
from interstitial space/CSF to the perivascular-perivenous drainage path.

5.2 Background
Effect of alcohol consumption and metabolism on vascular tissues yields biphasic
consequences that depend on drinking patterns: low alcohol intake leads to beneficial
effects while high amount of ingestion delivers detrimental results. Researchers found
that low dose alcohol improved vascular endothelial function through increased
endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production
[74]. For example, loading low dose alcohol to various cell types (e.g., human umbilical
vein endothelial cells, bovine aortic endothelial cells) elicited NO production, eNOS
protein expression [64, 104, 105] and corresponding mRNA expression [65]. A similar
phenomenon was observed in animal studies: low dose ethanol consumption in rats
increased nitric oxide production and eNOS expression in the aortic vascular wall [106].
Given that NO is known as an endothelium-mediated vessel dilator that regulates
vascular contractility, investigators found that low dose alcohol can exert a protective
effect towards vasculatures due to NO mediated vessels dilation. In vivo animal studies
showed that acute low dose EtOH intake increased release of NO, augmented
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endothelium-mediated vasodilatation [106-108] and decreased mean blood pressure
[106]. In a human multiethnic study, drinkers (between 1 drink/month and 2 drinks/day)
were more likely to have a higher flow-mediated dilation (FMD) than non-drinkers and
those who drank >2 drinks/day, independent of the type of alcoholic beverage consumed
[109], indicating beneficial vascular effects gained from low dose alcohol.
On the contrary, moderate/chronic alcohol consumption assumed an opposite
effect. For example, in a thoracic aorta isolated from chronic ethanol-fed rats, eNOS
expression and NO levels were down-regulated, leading to diminished vasorelaxation
[118]. In other studies, researchers observed that dilatation of rat basilar arteries or pial
arterioles was less in alcohol fed rats compared with non-alcohol-fed rats; while
superoxide dismutase and NAD(P)H oxidase inhibitor apocynin were able to ameliorate
the loss of function, suggesting that ROS induced by chronic alcohol may lead to
impaired eNOS-mediated vasodilation [119, 120]. In addition to what was described
above, alcohol-induced oxidative/nitrosative stress was known to cause vascular
damage. Alcohol-induced tissue injury was mediated via metabolism of ethanol by
alcohol dehydrogenase and cytochrome P450 2E1 that produced acetaldehyde and
reactive oxygen species/reactive nitrogen species (ROS/RNS) [111, 121]. Thus, tissue
injury was supposed to occur in cell types that expressed ethanol metabolizing or radical
generating enzymes, like inducible nitric oxide synthase (iNOS) [72, 122]. For example,
it is widely known that the blood-brain barrier (brain microvessels) is vulnerable to
alcohol-induced free radical damage. Haorah et al. revealed that alcohol metabolizing
enzymes have been shown to localize in the brain microvessel endothelium [111, 123,
124] and metabolism of alcohol in brain endothelium generates oxidative and nitrosative
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products that cause free radical damage to brain microvessels including the BBB [72,
111].
In previous findings [62], we described that alcohol promotes waste clearance in
the CNS via brain vascular reactivity. It is known that waste metabolites can be drained
out of the brain through various clearance systems, including enzymatic degradation,
cellular uptake, transport across the blood–brain barrier (BBB), and interstitial fluid
(ISF)/cerebrospinal fluid (CSF) absorption into the circulatory and lymphatic systems.
Out of those clearance routes, BBB trans-vascular clearance from brain to blood
provides functionally a major pathway for elimination of different waste metabolic
products from brain and accounts for > 80% of clearance of amyloid-beta physiological
conditions [59-61, 66]. However, large size waste metabolites like tauopathy, prion-like
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated
around the perivascular space in brain tissue from neurological diseases [1, 2, 48],
suggesting that large size waste metabolites are not cleared by CSF, glymphatic, or
meningeal lymphatic systems. We found that dynamic movement of large size waste
metabolites from interstitial space and subarachnoid towards perivascular space is
enhanced when interaction of brain vascular endothelial cells (ECs) and smooth muscle
cells (SMCs) is prompted [62]. Interestingly, low dose alcohol (5 mM) can facilitate this
process through up-regulation of NO since alcohol especially low dose was known to
increase eNOS expression [64, 65, 74, 104]. We showed that clearance of large size
waste metabolites was increased by low dose alcohol while NOS inhibitor neutralized
this effect, indicating the underlying mechanism of alcohol-elicited eNOS activation and
NO production [62].
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However, the pendulum shifts when it comes to chronic alcohol intake.
Epidemiological population-based cohort studies revealed that heavy alcohol use in
chronic condition was associated with development dementia and progression of
Alzheimer’s disease and cerebral amyloid angiopathy [5, 77, 80, 81, 83, 84, 125, 126],
the hallmark of these neurological diseases happen to be the deposition of waste
metabolites like Aβ protein, or protein prion-like proteinopathies around the
perivascular space [1, 2, 48]. These cohort studies also unequivocally noted the
protective effects of low dose alcohol use against the progression of dementia and
AD/CAA, with unknown mechanisms. Thus, it is apparent that the beneficial or
destructive effects of alcohol depend on the duration and concentration used.
In conclusion, we hypothesize the contrast effect of low dose and
chronic/moderate alcohol on brain waste metabolites clearance: low dose facilitates
clearance by acting as a vasodilator through activating eNOS and enhancing brain
vascular endothelial cells (ECs)-smooth muscle cells (SMCs) interaction, while
chronic/moderate condition hampers the clearance due to iNOS/free radicals mediated
impairment of ECs-SMCs interaction. The rationale is that activation of eNOS by low
concentrations of ethanol elevates physiological NO levels and augments ECs-SMCs
interactive reactivity whereas chronic/moderate causes free radical damage to
microvessels and leads to BBB dysfunction, reducing vascular dilative reactivities and
decreasing perivascular clearance.

5.3 Results
We investigated the contrast effects of low/acute and moderate/chronic alcohol on brain
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waste metabolites clearance in this study. Here, we first focused on bio-distribution of
2000 kDa fluorescent dye representing large size waste metabolites in three different
experimental conditions: control, low/acute alcohol (5 mM) and moderate/chronic
alcohol. Low dose was found to promote dynamic movement of tracers along the
perivascular space (PVS) while moderate/chronic showed an opposite effect. Further
examination revealed that low dose alcohol elicited eNOS activation and improved ECsSMCs interactive reactivity whereas chronic/moderate alcohol induced iNOS
expression that led to tissue damage at brain vasculatures including endothelium, smooth
muscle cells and blood-brain barrier (BBB) tight junction proteins, indicating that
chronic/moderate alcohol decreased vascular dilative reactivities and exerted
detrimental effect towards brain PVS clearance.
5.3.1 Animal Model of Liquid-Diet Alcohol Intake
To determine success of the pair-feeding procedure, we weighed and recorded rats’
weight on a weekly basis. At the time of sacrifice (12 weeks), the average body weight
was 428 ± 11.1 for pair-fed control and 451 ± 10.2 for pair-fed alcohol. This was
consistent with previous reports that pair-fed alcohol revealed overall higher body
weight distribution at the end of the feeding cycle compared with control [16]. Weekly
body weight record showed that at early feeding cycles, alcohol feeding showed lower
weight-gaining compared with control. That was because by nature animals required
enough time to acclimate to the taste of alcohol. Once accustomed (after week 4),
weight-gaining rate of alcohol rats exceeded that of control and weight of alcohol rats
started to approach and preceded control (after week 6).
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Table 5.1 Pair-feeding Rat Body Weight and Blood Alcohol Concentration Statistics
before Sacrifice (12 weeks after feeding)
Body weight (g) after 12 weeks pair-fed (n=15 pairs)

Blood alcohol
concentration (mM)

Gro

Mean

up
Cont

Standard

Median

Min

Max

Mean

Range

Deviation
428

11.1

429

399

449

0.002

0 – 0.005

451

10.2

451

437

468

15.6

9.1 – 28.8

rol
EtO
H

Prior to sacrificing, blood alcohol concentrations for all rats was determined to be
9.1 – 28.8 mmol/L in alcohol diet ingested animals (Table 5.1), which was consistent
with our previous results [127]. The huge variation in blood alcohol levels is common
in animal studies due to nocturnal feeding habits of rats and variation in ethanol
metabolic and clearance rate.
5.3.2 Injection of FITC-d2000 into C3 Region of CSF Flow under Control, Low
Dose Alcohol and Chronic Alcohol Conditions
To evaluate the contrast effects of low/acute and moderate/chronic alcohol on dynamic
movement and clearance of large size waste metabolites in the brain, we injected FITCd2000 (MW: 2000 KD) directly into the CSF flow via cisterna magna. We then
evaluated the bio-distribution of tracer in the brain two hours after injection under
different experimental conditions. We observed that low/acute alcohol enhanced tracer
movement along vasculatures whereas moderate/chronic hampered this process. For
example, in the low/acute study, more tracers were found at the perivascular spaces
(PVS) compared with control, which was in accordance with previous finding [62].
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However, opposite effect revealed under the moderate/chronic treatment. We barely
found any tracers at PVS two hours after injection in moderate/chronic condition,
suggesting that dynamic movement of tracers was decreased (Figure 5.1 Top A-I). This
qualitative data was further validated by quantification of arbitrary fluorescence
intensity at PVS (Figure 5.1 Bottom A, *** p<0.001).
In addition, to evaluate the clearance efficiency, we also examined fluorescence
intensity in systematic blood plasma collected from the jugular vein 2 hours after
injection. Data (Figure 5.1 Bottom B) suggested that clearance from inside the brain to
circulation was significantly (*** p<0.001) decreased in the chronic alcohol group
compare with control, which was in parrel with the PVS tracer movement results.
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Top:

Figure 5.1 Tracer bio-distribution in the rat brain under different experiment conditions.
Tracers were injected into the rats brain through cisterna magna and 2 hours were given
before sacrificing. Coronary brain slices (45 µm) mounted with Dapi on glass slides
were used for imaging. Top: [A, B and C]. Bio-distribution of CSF tracer (FITC-d2000,
green) in control, EtOH (low dose alcohol) and chronic alcohol groups. Scale bar: 1 mm.
[D-I]: Detail of corresponding boxed areas from A, B and C. Scale bar: 25 μm. Data
was representation of at least N=6 animals per each group.
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Bottom:

Figure 5.1 Bottom: [A]. Fluorescence intensity quantification of tracer biodistribution
at the PVS was calculated as mean fluorescence intensity on each slide (from N=6
animals, 10~15 slices were taken from each animal, +SEM) and presented as bar graphs.
Statistically significant (***p < 0.001) compared with controls. Three replicates were
done for each animal sample from at least N=6 animals. [B]. Blood plasma tracer
fluorescence intensity quantification. Samples were from N=6 animal per each group.
Statistically significant (***p < 0.001) compared with controls.
5.3.3 Contrast Effects of Low Dose and Moderate/Chronic Alcohol on Vascular
Smooth Muscles
To find out the reasons why chronic alcohol diminished PVS clearance efficiency, we
studied two vascular components: smooth muscles and endothelium. The ratioale was
that according to previous findings, PVS clearance was mediated by dilative vascular
reactivities, which were regulated by endothelium and smooth muscles interaction.
Firstly, we investigated vascular smooth muscles. Immunostaining of α-SMCs
(smooth muscel actin, red) showed increasing expression in the low/acute alcohol group
compared with control whereas expression of α-SMCs in the chronic condition was
decreased (Figure 5.2A). The observation was validated by quantitative assay western
blot (Figure 5.2B), collectively suggesting that chronic alcohol intake impaired smooth
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muscle actins, which respresents the architectural structure of smooth muscle cells.
We further examined the phosphorylation level of myosin light chain (MLC),
which represents the contraction (phosphorylation) or relaxation (de-phosphorylation)
status of smooth muscles. Immunostaining (smooth muscle specific p-MLC, green)
showed that phosphorylation level of MLC was decreased by low dose (Figure 5.2 A),
indicating enhanced dilative vascular reactivities. Whereas in the chronic condition, pMLC level was increased, suggesting that the vascular dilative reactivities were
diminished. The observation was validated by quantitative assay western blot (Figure
5.2 B). As such, the summary is that chronic alcohol intake impaired vascular smooth
muscles and decreased dilative vascular reactivities.

Figure 5.2 Effect of low dose and chronic alcohol intake on vascular smooth muscle
reactivity. [A].Immunostaining of SMA (red) and smooth muscle specific phosphoMLC (green) protein at brain microvessels (indicated by structures) in control, low dose
EtOH and chronic EtOH treatment. SMA and p-MLC were used as primary antibodies.
Data was representation of at least N=6 animals per each group. Scale bar: 30 μm. [B].
Immunoreactive bands of SMA, p-MLC and β-actin, and quantitative corresponding
protein content in three experimental groups. Results were expressed as the ratio of
protein of interest to that of actin bands and presented as mean values (± SEM).
Statistically significant (*p<0.05) compared with controls. Three replicates were done
for each animal sample from at least N=6 animals.
5.3.4 Contrast Effect of Low Dose and Moderate/chronic Alcohol on Brain
Vascular Endothelial cells and the Blood-Brain Barrier (BBB)

To investigate the effect of alcohol on brain vascular endothelial cells, we evaluated the
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immunoreactivity of endothelial cell markers, von willebrand factor (vWF) and glucose
transporter 1 (Glut-1). Immunostaining revealed that chronic alcohol intake diminished
aimed proteins’ (vWF and Glut-1) expressions while there was no change for low/acute
exposure, which was further validated by western blot analyses (*p<0.05) (Figure 5.3).
These results indicated that chronic alcohol impaired brain vascular endothelial cells
compared with control and low dose.
Next, we procceded to investigate the integrity of blood-brain barriers (BBB),
which were localized on the endothelium. We examined changes in expression of BBB
tight junction (TJ) proteins: occludin, claudin-5 and zonula occluden 1 (ZO-1) by
immunostaining and western blot since reduction in TJ protein levels or disruption of
the architectural structure of any TJ protein was expected to impair BBB integrity.
Immunostaining revealed that moderate/chronic alcohol exposure diminished
expression of TJ proteins at brain microvessels compared with control (Figure 5.4A)
while no significant change was observed in low/acute alcohol. These alcohol dosinginduced changes in TJ protein expressions were validated by western blot, and
quantification of the TJ protein immunoreactive bands (p<0.05) (Figure 5.4B). This
data was in agreement with previous findings that chronic alcohol abuse leads to
breaking of the BBB [88, 89, 111].
In summary, we concluded that moderate/chronic alcohol intake impaired brain
vascular endoethelial cells and compromised BBB integrities.
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Figure 5.3 Effect of low dose and chronic alcohol intake on vascular endothelial cells.
Coronal tissue sections (10 ~ 15 μm) were analyzed for endothelial cell markers (vWF
and Glut-1: red) subcellular distribution while protein extracts from brain were analyzed
for alterations in corresponding protein content. [A]. Immunostaining of vWF (red) and
Glut-1 (red) protein around brain microvessels (indicated by circular structures) in
control, low dose EtOH and chronic EtOH treatment. vWF and Glut-1 were used as
primary antibodies (information in Table 2.1). Scale bar: 30 μm. Data was representation
of at least N=6 animals per each group. [B]. Immunoreactive bands of vWF, Glut-1 and
β-actin, and quantitative corresponding protein content in three experimental groups.
Results are expressed as the ratio of protein of interest to that of actin bands and
presented as mean values (± SEM). Statistically significant (*p < 0.05) compared with
controls. Three replicates were done for each animal sample from at least N=6 animals.
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Figure 5.4 Effect of low dose and chronic alcohol intake on BBB tight junction proteins.
[A]. Immunostaining of tight junction proteins: ZO-1, Occludin and Claudin-5 (red) in
brain microvessels from coronal slices (10 ~ 15 μm) of control, low dose EtOH and
chronic EtOH. ZO-1, Occludin and Claudin-5 were used as primary antibodies
(information in Table 2.1). Scale bar: 30 μm. Data was representation of at least N=6
animals per each group. [B]. Western blot analysis of ZO-1, Occludin, Claudin-5 and βactin in the whole brain tissue homogenates of rats at different experimental conditions.
Results are expressed as the ratio of protein of interest to that of actin bands and
presented as mean values (± SEM). Statistically significant (*p < 0.05) compared with
controls. Three replicates were done for each animal sample from at least N=6 animals.

5.3.5 Induction of Free Radicals by Alcohol Causes Vasculature Damage
From previous data, it was shown that smooth muscles, endothelium and BBB integrities
were impaired under chronic alcohol exposure. To find out the likely reasons that caused
these observations, we focused on free radical generation - particularly the iNOS
mediated nitrosative stress on brain vasculatures. Level of 3-nitrotyrosine (3-NT) was
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the indicator of nitrosative stress, as it leads to formation of nitrated proteins.
Immunostaining of 3-NT revealed that protein level was increased in the chronic
condition while no change in the low/acute when compared with control (Figure 5.5A).
Using the western blot assay, we detected three nitrotyrosine proteins (molecular
weights of 210, 97, and 68 kDa). The 210‐kDa protein was the major nitrated protein as
compared with 97 kDa or 68 kDa nitrated proteins. Quantitative data validated our
finding that chronic exposure significantly increased 3-NT expression (Figure 5.5B)
(*p<0.05). The extent of nitrosative damage marker 3NT paralleled induction of iNOS,
indicating that free radical damage was correlated with iNOS over-expression. eNOS
expression was elevated under low dose condition, which lined-up with previous
observations.
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Figure 5.5 Effect of low dose and chronic alcohol intake on free radical generation.
Coronal tissue sections (10 ~ 15 μm) were analyzed for eNOS, iNOS and 3-NT
(nitrosative stress markers) subcellular distribution while protein extracts from brain
were analyzed for alterations in corresponding protein content. [A]. Immunostaining of
eNOS (red), iNOS (red) and 3-NT (red) protein at brain microvessels (indicated by
structures) in control, low dose EtOH and chronic EtOH. eNOS, iNOS and 3-NT were
used as primary antibodies (information in Table 2.1). Scale bar: 30 μm. Data was
representation of at least N=6 animals per each group. [B]. Immunoreactive bands of
eNOS, iNOS, 3-NT and β-actin, and quantitative corresponding protein content in three
experimental groups. Results were expressed as the ratio of protein of interest to that of
actin bands and presented as mean values (± SEM). Statistically significant (*p < 0.05)
compared with controls. Three replicates were done for each animal sample from at least
N=6 animals.

Thus, these data above collectively suggested that iNOS mediated nitrosative
stress leads to free radical damage at brain vasculatures when exposed to the
moderate/chronic alcohol whereas no such effect was found on the low/acute.
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5.4 Discussion
We discuss the finding of contrast effects of alcohol (acute/low and moderate/chronic) on
brain PVS waste metabolites clearance. In a previous study [62], we used low levels of
alcohol to understand the protective mechanisms of promoting perivascular clearance
because low alcohol use was protective of vascular and cardiovascular function [4, 64, 65,
85-87]. We found that low dose alcohol intake (5 mM) can increase interaction of brain
vascular ECs-SMCs. Large size waste metabolites clearance in the brain that cannot be
efficiently done through CSF, glymphatic, or meningeal lymphatic systems were able to
be facilitated by alcohol through this mechanism. In fact, Lundgaard et al. (2018) showed
the beneficial effects of low dose alcohol and the adverse effects of high dose alcohol on
glymphatic function [85]. We noted here that the contrast effects of low dose alcohol
intake and chronic use of moderate-to-high dose alcohol (equivalent of alcohol dependent
subjects) were examined in the context of vascular reactivity, blood-brain barrier
permeability and perivascular clearance since epidemiological evidence showed
distinctive consequences on brain clearance and associated neurological diseases (e.g.,
Alzheimer’s disease and cerebral amyloid angiopathy) under different alcohol drinking
patterns as discussed previously [5, 77, 80, 81, 83, 84, 125, 126]. The data indicated that
chronic alcohol hampered perivascular waste metabolites clearance, impaired dilative
vascular reactivities and compromised BBB integrity, due to: 1) paradigm shift to iNOS
in chronic conditions and 2) free radical damage induced by alcohol impaired brain
microvessels during moderate/chronic alcohol exposure.
To mimic the large size waste metabolites, we injected a large molecular weight
fluorescent tracer (2000 KD) as proof-of-concept. We showed the contrast phenomenon
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by examining the bio-distribution of large size molecular weight fluorescent tracer
through cisterna magna injection under low/acute and moderate/chronic conditions
(Figure 5.1). We found that low/acute alcohol enhanced dynamic tracer movement and
clearance while moderate/chronic hampered this process. Further evidence showed that
vascular smooth muscles and endothelium were impaired and BBB intergrites were
compromised under chronic alcohol conditons (Figures 5.2 – 5.4), indicating that the
vascular dilative reactivities that are regulated by endothelial-smooth muscle interaction
were diminished.
We also examined the expression of iNOS (Figure 5.5), which mediated free
radical generating due to elevation of high amounts of NO compared with that of eNOS.
Interestingly, iNOS showed an opposite expression pattern compared with eNOS. We
then showed that free radical damages (3-NT) (Figure 5.5) that induced by chronic
alcohol exposure impaired brain microvessels, which were in parallel with iNOS
expression.
Collectively, the contrast effects of acute/low and chronic/moderate alcohol intake
were examined in this chapeter. It was found that unlike low dose, moderate/chronic
alcohol intake diminished PVS clearance compared with control. The contrast effects
were due to that moderate/chronic alcohol induced free radical generation, which led to
impairement of vascular endothelium and smooth muscles, dysfunction of BBB and
decreased vascular dilative reactivities. The significance of this work is the discovery
that mis-use/chronic alcohol abuse impairs the brain clearance system, which may lead
to onset/progression of neurodeneration diseases, like Alzheimer’s disease, supporting
by epidemiological studies that discussed previously.

97

Figure 5.6 Illustration of Chapter 5. Left: Arrows (orange) indicate the CSF
subarachnoid flow and perivascular-perivenous clearance path (black) of large size
waste metabolites (red dots) in the neurodegenerative brain. Waste metabolites like betaamyloid proteins are aggregated more inside the interstitial space due to the lack of a
lymphatic system in the brain. Less metabolites drain into the CSF flows due to less
vessel dilative reactivity. Right top: The neurodegenerative brain in the presence of low
dose alcohol. Dilative arterial vessel reactivity promotes the dynamic movement of large
size waste metabolites from interstitial fluid to perivascular space and from interstitialCSF subarachnoid to perivascular space. Reactivity of endothelial and smooth muscle
cells in arteries is mediated by alcohol-initiated eNOS activation and NO production.
Right bottom: The neurodegenerative brain exposed to chronic/moderate alcohol intake.
Loss of dilative arterial vessel reactivity due to free radical damage towards vasculatures
hampers the dynamic movement of waste metabolites to the perivascular – peri-venous
route. Paradigm shift from eNOS to iNOS initiates free radical generation and causes
diminishing reactivity of endothelial and smooth muscle cells in arterial vasculatures
with chronic/moderate alcohol exposure.
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CHAPTER 6
SUMMARY CONCLUSION

Efficient clearance of the interstitial waste metabolites is essential for normal
maintenance of brain homeostasis. The brain lacks the lymphatic clearance system –
thus clearance of waste metabolites in the brain is dependent on cerebrospinal fluid
(CSF) system. The recent discovery glymphatic system claims that the direct bulk flow
transports small size water-soluble waste metabolites into to the perivenous space by
aquaporin-4 water channels of the astrocyte end-feet, but it does not account for the
clearance of large size waste metabolites, like peptide and/or protein aggregations.
Here, the clearance mechanisms of large size waste metabolites from interstitial
fluid to the perivascular space as well as from the CSF subarachnoid into perivascular
space via the paravascular drainage is investigated. A low dose ethanol (5 mM) is found
to promote the dynamic clearance of waste metabolites through this perivascularperivenous drainage path. This ethanol-induced effect can be explained by the findings
that activation of endothelial specific nitric oxide synthase (eNOS) by ethanol and
generation of vasodilator nitric oxide (NO) mediate the interactive reactivity of
endothelial-smooth muscle cells. Futher evidence reveals that NO mediated ECs and
SMCs interaction is regulated by myosin light chain activities, which depend on the
balance between two opposite enzymatic acitivies: myosin light chain kinase and
myosin light chain phosphatase.
In addition to that, the contrast effects of acute low dose and chronic moderate
alcohol intake on BBB associated perivascular clearance of waste metabolites in the
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brain is also examined. The underlying molecular and cellular mechanisms that drive
the increase or decrease movement of tracer to perivascular space by acute/chronic
alcohol exposure are correlated to BBB integrity and arterial vessel reactivity. Evidently,
the contrast effects of alcohol appear to be regulated by the switch mechanisms of
endothelial specific nitric oxide synthase (eNOS) activation by low dose and inducible
NOS (iNOS) by moderately high alcohol exposure in chronic conditions. As such, it is
concluded that low dose alcohol promotes the diffusive movement of waste metabolites
to perivascular clearance through eNOS-derived NO regulated arterial endothelialsmooth muscle cell dilative reactivity without affecting the integrity of the BBB.
Whereas, continuous induction of iNOS in chronic alcohol exposure causes oxidative
damage of the arterial endothelial-smooth muscle layers that led to BBB dysfunction,
reduced dilative reactivity, and decreased movement of waste metabolites from
interstitial space/CSF to perivascular-perivenous drainage path.
Given the fact that large size waste metabolites like tauopathy, prion-like
proteinopathies, cerebral amyloid angiopathy, and Aβ proteins are seen accumulated
around the perivascular space in brain tissue from neurological diseases, the significance
of this current work affords new therapeutical strategies for neurological diseases,
particarly the timely clearance of entangled proteins.
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APPENDIX A
MATLAB CODE FOR COMPUTING VESSEL DIAMETER CHANGE
This code is used to calculate vessel diameters that present in Chapter 3.
%%
folderContents = dir;
nFiles = length(dir);
arteryFiles = cell(nFiles,1);
nVids = 0;
for i = 1:nFiles
filename = folderContents(i).name;
if length(filename) > 3 && strcmpi(filename(1:2),'T=') && strcmpi(filename(end-3:end),'.avi')
nVids = nVids + 1;
arteryFiles{nVids} = filename;
end
end
arteryFiles = arteryFiles(1:nVids);
exposureTimes = zeros(nVids,1);
for i = 1 :nVids
exposureTimes(i) = str2double(arteryFiles{i}(3:end-4));
end
%%
nDivisions = 5;
peakQuantile = .9;
pixelLength = 40/38;
vesselDiameterYLim = [15,35];
interpFactor = 8;
frameRate = 4;
borderFraction = .1;
vesselDiameters = cell(nVids,1);

for i = 1:nVids
vw = VideoWriter(['T',num2str(exposureTimes(i)),'_vessel_diameters']); %#ok<TNMLP>
vw.FrameRate = frameRate;
open(vw);
cf = figure('units','normalized','outerposition',[0 0 1 1]);
% set(cf,'visible','off')
exposureTimes(i) = str2double(arteryFiles{i}(3:end-3));
currentVideo = importdata(arteryFiles{i});
nX = size(currentVideo(1).cdata,2);
nY = size(currentVideo(1).cdata,1);
nFrames = length(currentVideo);
vesselDiameters{i} = zeros(nFrames,nDivisions);
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for j = 1:nFrames;
iRed = currentVideo(j).cdata(:,:,1);
iFilt = double(iRed);
iFilt = filter2(eye(3)/9,iFilt);
iFilt = medfilt2(iFilt,[1,3]);

clf
subplot(1,3,1)
imshow(currentVideo(j).cdata)

for k = 1:nDivisions

y = round(k/(nDivisions+1)*(nY*(1-2*borderFraction)) + nY*borderFraction); %divide up only the
middle half to avoid text at head and foot of video
interpX = linspace(1,nX,nX*interpFactor);
lineVals = interp1((1:nX),iFilt(y,:),interpX);
mpp = 2*median(lineVals);
[~, peaks] = findpeaks(lineVals,'MinPeakProminence',mpp);
if numel(peaks) > 1
leftPeak = min(peaks);
rightPeak = max(peaks);
vesselDiameters{i}(j,k) = range(interpX(peaks))*pixelLength;
%
vesselDiameters{i}(j,k) = min(diff(sort((interpX(peaks))*pixelLength)));
else
vesselDiameters{i}(j,k) = 0;
end

subplot(1,3,1)
hold on
plot([1,nX],[y,y],'b','linewidth',2)
if ~isempty(peaks)
plot(interpX(peaks),y,'w.','markersize',12)
end
subplot(nDivisions,3,2+(k-1)*3)
hold on
plot(interpX,lineVals,'linewidth',2)
plot(interpX(peaks),lineVals(peaks),'k.','markersize',12);

if k == 1
title(arteryFiles{i}(1:end-4))
end
if k == nDivisions
xlabel('distance (\mum)')
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end
ylabel('relative intensity')
subplot(nDivisions,3,3+(k-1)*3)
hold on
plot((0:j-1)/frameRate,vesselDiameters{i}(1:j,k),'.')
xlim([0,nFrames]/frameRate)
ylim(vesselDiameterYLim)
if k == nDivisions
xlabel('time (s)')
end
ylabel('distance (\mum)')

end
set(cf,'color','w')
vw.writeVideo(getframe(cf));
%
pause(.01)
end
close(vw)

end

103

APPENDIX B
R CODE FOR VESSEL DIAMETER DATA PROCESS AND PLOTTING

This code is used to generate plots that present in Chapter 3.
# read data
T0<-read.csv('T=0.csv',header = F)
T15<-read.csv('T=15.csv',header = F)
T30<-read.csv('T=30.csv',header = F)
T45<-read.csv('T=45.csv',header = F)
# rename column
colnames(T0)<-c('Frame','1','2','3','4','5')
colnames(T15)<-c('Frame','1','2','3','4','5')
colnames(T30)<-c('Frame','1','2','3','4','5')
colnames(T45)<-c('Frame','1','2','3','4','5')
# add label
T0$time<-'baseline'
T15$time<-'15 min after alcohol'
T30$time<-'30 min after alcohol'
T45$time<-'45 min after alcohol'
# plot
T0reshape<-melt(T0,id.vars = 'Frame')
T0reshape$variable<-NULL
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame))
T0sum<T0reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
T0sum$Frame<as.numeric(as.character(T0sum$Frame))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean))

plotfunction<-function(a){
x1<-melt(a,id.vars = 'Frame')
x1$variable<-NULL
x1$Frame<-as.factor(as.character(x1$Frame))
x2<x1%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
x2$Frame<as.numeric(as.character(x2$Frame))
spline_int<-as.data.frame(spline(x2$Frame, x2$mean))
ggplot(x2,aes(x=Frame,y=mean))+
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geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
}
plotfunction(T30)
T30<-T30[-12,]
T30
row.names(T30) <- 1:nrow(T30)
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point()
# encoding time lapse
T15$Frame<-T15$Frame+40
T30$Frame<-T30$Frame+77
T45$Frame<-T45$Frame+116
combine<-rbind(T0,T15,T30,T45)
combine<-combine[-c(89,90),]
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114)
combine[combine$time=='45 min after alcohol','Frame']<-seq(115,191)
combine_reshape<-melt(combine,id.vars = c('Frame','time'))
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame))
combine_reshape_sum<combine_reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
combine_reshape_sum$Frame<as.numeric(as.character(combine_reshape_sum$Frame))
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30
min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse)
is.factor(combine_reshape_sum$timelapse)
combine_reshape_sum$label<-NULL
# Plot for the combine
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean))
p<ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
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# add theme
p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=15),
axis.title.y = element_text(size=15),
axis.text.x=element_text(color="Black",size=10),
axis.text.y = element_text(color="Black",size=10),
plot.title = element_text(size=15,hjust=0.5),
panel.background = element_rect(fill='White',color='Black'))
# plot
T0reshape<-melt(T0,id.vars = 'Frame')
T0reshape$variable<-NULL
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame))
grouped<-group_by(T0reshape,Frame)
summarise(grouped,mean=mean(value),sd=sd(value))
T0sum<T0reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
View(T0sum)
T0sum$Frame<as.numeric(as.character(T0sum$Frame))
View(T0sum)
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) +
library("ggplot2", lib.loc="~/R/win-library/3.4")
ggplot(T0sum, aes(x=Frame, y=mean) +
str(T0sum)
str(T0sum)
summary(T0sum)
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) +
geom_point()
geom_line() +
gplot(T0sum, aes(x=Frame, y=mean) +
geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) +
geom_line() +
geom_point()
gplot(T0sum, aes(x=Frame, y=mean)
gplot(T0sum, aes(x=Frame, y=mean)+geom_errorbar(aes(ymin=mean-sd, ymax=mean+sd), width=.1) +
ggplot(T0sum,aes(x=Frame,y=mean))
ggplot(T0sum,aes(x=Frame,y=mean))
View(T0sum)
ggplot(T0sum,aes(x=Frame,y=mean))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+geom_line()
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~ploy(x,39))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
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geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~poly(x,39))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~poly(x,10))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~poly(x,38))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~poly(x,30))
formula = y~poly(x,20)
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
stat_smooth(aes(x=Frame,y=mean),method = 'lm',
formula = y~poly(x,20))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
plotfunction<-function(a){
x1<-melt(a,id.vars = 'Frame')
x1$variable<-NULL
x1$Frame<-as.factor(as.character(x1$Frame))
x2<x%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
x2$Frame<as.numeric(as.character(x2$Frame))
spline_int<-as.data.frame(spline(x2$Frame, x2$mean))
ggplot(x2,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
}
plotfunction(T0)
plotfunction(T0)
T0reshape<-melt(T0,id.vars = 'Frame')
T0reshape$variable<-NULL
T0reshape$Frame<-as.factor(as.character(T0reshape$Frame))
T0sum<T0reshape%>%
group_by(Frame)%>%
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summarise(mean=mean(value),sd=sd(value))
T0sum$Frame<as.numeric(as.character(T0sum$Frame))
ggplot(T0sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
spline_int<-as.data.frame(spline(T0sum$Frame, T0sum$mean))
plotfunction<-function(a){
x1<-melt(a,id.vars = 'Frame')
x1$variable<-NULL
x1$Frame<-as.factor(as.character(x1$Frame))
x2<x1%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
x2$Frame<as.numeric(as.character(x2$Frame))
spline_int<-as.data.frame(spline(x2$Frame, x2$mean))
ggplot(x2,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
}
plotfunction(T0)
plotfunction(T15)
plotfunction(T30)
plotfunction(T45)
View(T45)
View(T30)
T45<-read.csv('T=45.csv',header = F)
colnames(T45)<-c('Frame','1','2','3','4','5')
plotfunction(T45)
View(T0)
View(T15)
View(T30)
View(T45)
# add label
T0$time<-'baseline'
T15$time<-'15 min after alcohol'
T30$time<-'30 min after alcohol'
T45$time<-'45 min after alcohol'
View(T0)
combine<-rbind(T0,T15,T30,T45)
View(combine)
View(T0)
View(T15)
T15$Frame<-T15$Frame+40
View(T15)
View(T15)
View(T30)
T30$Frame<-T30$Frame++77
View(T30)
T30$Frame<-T30$Frame+77
View(T30)
T30<-read.csv('T=30.csv',header = F)
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colnames(T30)<-c('Frame','1','2','3','4','5')
T30$time<-'30 min after alcohol'
View(T30)
T30$Frame<-T30$Frame+77
T45$Frame<-T45$Frame+116
combine<-rbind(T0,T15,T30,T45)
View(combine)
combine_reshape<-melt(combine,id.vars = 'Frame')
View(combine_reshape)
combine<-rbind(T0,T15,T30,T45)
combine_reshape<-melt(combine,id.vars = c('Frame','time'))
View(combine_reshape)
combine$Frame<-as.factor(as.character(combine$Frame))
combine<-rbind(T0,T15,T30,T45)
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame))
combine_reshape_sum<combine_reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
combine_reshape_sum$Frame<as.numeric(as.character(combine_reshape_sum$Frame))
View(combine_reshape_sum)
View(combine_reshape_sum)
View(combine_reshape)
combine_reshape_sum<combine_reshape%>%
group_by(Frame)%>%
summarise(time=time,mean=mean(value),sd=sd(value))
combine_reshape_sum$Frame<as.numeric(as.character(combine_reshape_sum$Frame))
View(combine_reshape_sum)
View(combine_reshape_sum)
View(T0)
View(T15)
View(T30)
View(T45)
combine_reshape_sum$label<-ifelse(combine_reshape_sum$Frame>=117,'45min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
View(combine_reshape_sum)
is.numeric(combine_reshape_sum$Frame)
# Plot for the combine
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y,color=label))
View(combine_reshape_sum)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
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geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=label),inherit.aes = FALSE)+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
View(combine_reshape_sum)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
combine_reshape_sum$label<-NULL
combine_reshape_sum$label<-NULL
View(combine_reshape_sum)
# Plot for the combine
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_point()+
head(combine_reshape_sum)
head(combine_reshape_sum)
head(combine_reshape_sum)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_point()+
head(combine_reshape_sum)
head(combine_reshape_sum)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
# Plot for the combine
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean))
geom_point()+geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)+
geom_point()+geom_line(data = spline_int,aes(x=x,y=y))
head(combine_reshape_sum)
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse)
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+geom_line(data = spline_int,aes(x=x,y=y))
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
p<-ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
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p
View(combine_reshape_sum)
is.factor(combine_reshape_sum$timelapse)
is.character(combine_reshape_sum$timelapse)
as.factor(combine_reshape_sum$timelapse)
is.factor(combine_reshape_sum$timelapse)
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse)
is.factor(combine_reshape_sum$timelapse)
spline_int<-as.data.frame(spline(combine_reshape_sum$Frame, combine_reshape_sum$mean))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y,color=timelapse))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,colour=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,fill=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,fill=timelapse))+geom_point()+geom_line(data = spline_int,aes(x=x,y=y))
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,color=timelapse))+geom_point()+geom_line(data = spline_int,aes(x=x,y=y))
summary(combine_reshape_sum)
ggplot(data=combine_reshape_sum,
aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+geom_point()+geom_line(data =
spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_linegeom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)
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spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean))
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame,
y=combine_reshape_sum$mean,color=combine_reshape_sum$timelapse))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_fill_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse)
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
combine_reshape_sum[,combine_reshape_sum$mean<10]
combine_reshape_sum[combine_reshape_sum$mean<10,]
backup<-combine_reshape_sum
backup[backup$mean<10,]<-NULL
backup[66,]
backup[89,]
backup[89,]
View(combine_reshape_sum)
View(combine_reshape_sum)
backup[182,]
backup<-backup[-182,]
View(backup)
ggplot(backup,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
T30
T30[-12,]
T30<-T30[-12,]
T30
plotfunction(T30)
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plotfunction<-function(a){
x1<-melt(a,id.vars = 'Frame')
x1$variable<-NULL
x1$Frame<-as.factor(as.character(x1$Frame))
x2<x1%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
x2$Frame<as.numeric(as.character(x2$Frame))
spline_int<-as.data.frame(spline(x2$Frame, x2$mean))
ggplot(x2,aes(x=Frame,y=mean))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.1)+
geom_point()+
geom_line(data = spline_int,aes(x=x,y=y))
}
plotfunction(T30)
ggplot(data=T30,aes(x=Frame,y=mean))+geom_line
ggplot(data=T30,aes(x=Frame,y=mean))+geom_line()
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point()
row.names(T30) <- 1:nrow(T30)
ggplot(data=T30,aes(x=Frame,y=mean))+geom_point()
View(T30)
T30
View(T0)
View(T15)
View(T30)
T30$Frame<-T30$Frame+77
T30<-read.csv('T=30.csv',header = F)
colnames(T30)<-c('Frame','1','2','3','4','5')
T30$time<-'30 min after alcohol'
T30$Frame<-T30$Frame+77
View(T30)
View(T45)
combine<-rbind(T0,T15,T30,T45)
combine_reshape<-melt(combine,id.vars = c('Frame','time'))
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame))
combine_reshape_sum<combine_reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
combine_reshape_sum$Frame<as.numeric(as.character(combine_reshape_sum$Frame))
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse)
is.factor(combine_reshape_sum$timelapse)
combine_reshape_sum$label<-NULL
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
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theme(legend.title=element_blank())
View(combine_reshape_sum)
View(combine)
View(combine_reshape)
View(combine)
combine<-combine[-89,]
View(combine)
combine<-combine[-c(89,90),]
combine[combine$time=='30 min after alcohol',]
combine[combine$time=='30 min after alcohol','Frame']
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114)
seq(78,114)
combine<-rbind(T0,T15,T30,T45)
combine<-combine[-c(89,90),]
combine[combine$time=='30 min after alcohol','Frame']
combine[combine$time=='30 min after alcohol','Frame']<-seq(78,114)
combine[combine$time=='45 min after alcohol','Frame']
combine[combine$time=='45 min after alcohol','Frame']<-seq(115,191)
combine_reshape<-melt(combine,id.vars = c('Frame','time'))
combine_reshape$Frame<-as.factor(as.character(combine_reshape$Frame))
combine_reshape_sum<combine_reshape%>%
group_by(Frame)%>%
summarise(mean=mean(value),sd=sd(value))
combine_reshape_sum$Frame<as.numeric(as.character(combine_reshape_sum$Frame))
combine_reshape_sum$timelapse<-ifelse(combine_reshape_sum$Frame>=117,'45 min after alcohol',
ifelse(combine_reshape_sum$Frame<117&combine_reshape_sum$Frame>=78,'30 min after alcohol',
ifelse(combine_reshape_sum$Frame<78&combine_reshape_sum$Frame>=41,'15 min after
alcohol','baseline')))
combine_reshape_sum$timelapse<-as.factor(combine_reshape_sum$timelapse)
is.factor(combine_reshape_sum$timelapse)
combine_reshape_sum$label<-NULL
spline_int<-as.data.frame(spline(x=combine_reshape_sum$Frame, y=combine_reshape_sum$mean))
ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
P<ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
p<ggplot(combine_reshape_sum,aes(x=Frame,y=mean,color=timelapse))+
geom_errorbar(aes(ymin=mean-sd,ymax=mean+sd),width=0.5)+geom_point()+
geom_line(data = spline_int,aes(x=x,y=y),inherit.aes = FALSE)+
scale_color_discrete(breaks=c('baseline','15 min after alcohol','30 min after alcohol','45 min after
alcohol'))+
theme(legend.title=element_blank())
p
# add theme
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p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=20),
axis.title.y = element_text(size=20),
axis.text.x=element_text(color="Black",size=15),
axis.text.y = element_text(color="Black",size=15),
plot.title = element_text(size=20,hjust=0.5))
# add theme
p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=10),
axis.title.y = element_text(size=10),
axis.text.x=element_text(color="Black",size=5),
axis.text.y = element_text(color="Black",size=5),
plot.title = element_text(size=10,hjust=0.5))
# add theme
p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=15),
axis.title.y = element_text(size=15),
axis.text.x=element_text(color="Black",size=10),
axis.text.y = element_text(color="Black",size=10),
plot.title = element_text(size=15,hjust=0.5))
# add theme
p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=15),
axis.title.y = element_text(size=15),
axis.text.x=element_text(color="Black",size=10),
axis.text.y = element_text(color="Black",size=10),
plot.title = element_text(size=15,hjust=0.5),
panel.background = element_rect(fill='White'))
# add theme
p+xlab("Frame")+ylab("Diameter (um)")+
ggtitle("Cerebral vessel diameter change under low dose alochol")+
theme(axis.title.x = element_text(size=15),
axis.title.y = element_text(size=15),
axis.text.x=element_text(color="Black",size=10),
axis.text.y = element_text(color="Black",size=10),
plot.title = element_text(size=15,hjust=0.5),
panel.background = element_rect(fill='White',color='Black'))
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APPENDIX C
TIME COURSE VESSEL DIAMETER CHANGE PLOT

The plots that are presented here are used to support Chapter 3.
Figure C.1 Time course vessel diameter change

Figure C.2 Vessel diameter amplitude change at different time point

*

116

*

*

APPENDIX D
VALIDATION OF USING FITC-D2000 TRACERS AS MIMIC OF LARGE
SIZE WASTE METABOLITES

The figures serve to validate the tracers that are used in experiments.
Figure D.1 Bio-distribution comparison of A-beta and FITC-d2000 tracers following
intra-cranial injection (scale bar: whole brain: top: 500 μm, bottom: 1 mm; magnified
vessels: 30 μm)
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Figure D.2 Bio-distribution comparison of A-beta and FITC-d2000 tracers following
CSF injection (scale bar: whole brain: 1 mm; magnified vasculatures: 50 μm)
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APPENDIX E
NO DOSE AND TIME DEPENDENT EFFECT IN LOW DOSE ALCOHOL
TREATMENT
The figures examine dose- and time- dependent effects of low dose alcohol.
Figure E.1 No dose dependent effect on bio-distribution was found in low dose
alcohol treatment (2.5 mM – 20 mM; 2 hours post-dose; scale bar: 1 mm)
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Figure E.2 No dose dependent effect on NO production and eNOS expression was
found in low dose alcohol treatment (2.5 mM – 20 mM; 2 hours post-dose)

*

*

*

*

*

*

*
*

Figure E.3 No time dependent (2 hours, 5 days, 15 days and 20 days) effect on biodistribution was found in low dose alcohol treatment (5 mM; 2 hours post-dose; scale
bar: 1 mm)
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APPENDIX F
POSTIVE CONTROL OF TRACER BIODISTRIBUTION COMPARED WITH
EFFECT OF ALCOHOL
The figure is positive control comparing with effects of low dose alcohol.
Figure F.1 Effect of Nitric Oxide (NO) donor S-Nitroso-N-acetylpenicillamine
(SNAP: 100 μM, equivalent to 0.02 mg/mL through i.v injection) on tracer
biodistribution (scale bar: 1 mm)
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